0001140361-17-043457.txt : 20171121 0001140361-17-043457.hdr.sgml : 20171121 20171121120226 ACCESSION NUMBER: 0001140361-17-043457 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 39 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171121 DATE AS OF CHANGE: 20171121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Life Partners Position Holder Trust CENTRAL INDEX KEY: 0001692144 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 816950788 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55783 FILM NUMBER: 171215892 BUSINESS ADDRESS: STREET 1: 1717 MAIN STREET, SUITE 4200 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 214-462-6400 MAIL ADDRESS: STREET 1: 1717 MAIN STREET, SUITE 4200 CITY: DALLAS STATE: TX ZIP: 75201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Life Partners IRA Holder Partnership, LLC CENTRAL INDEX KEY: 0001705222 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 000000000 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55784 FILM NUMBER: 171215893 BUSINESS ADDRESS: STREET 1: 204 WOODHEW CITY: WACO STATE: TX ZIP: 76712 BUSINESS PHONE: 254-751-7797 MAIL ADDRESS: STREET 1: 204 WOODHEW CITY: WACO STATE: TX ZIP: 76712 10-Q 1 form10q.htm 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549-1004

FORM 10-Q

☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 000-55783

Commission file number 000-55784

LIFE PARTNERS POSITION HOLDERS TRUST

LIFE PARTNERS IRA HOLDER PARTNERSHIP, LLC

(Exact name of registrants as specified in their charters)

State of Texas State of Texas		81-6950788 81-4644966
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Nos.)

1717 Main St., Suite 4200, Dallas TX		75201
(Address of principal executive offices)		(Zip Code)

214-698-7893

(Registrants’ telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. Yes ☐ No ☑

Indicate by check mark whether the registrants have submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrants were required to submit and post such files). Yes ☑ No ☐

Indicate by check mark whether the registrants are large accelerated filers, accelerated filers, non-accelerated filers smaller reporting companies, or emerging growth companies. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filers ☐ Accelerated filers ☐ Non-accelerated filers ☐

Smaller reporting companies ☑ Emerging growth companies ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrants are shell companies (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

Indicate by check mark whether the registrants have filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934, subsequent to the distribution of securities under a plan confirmed by a court. . Yes ☐ No ☑

PART I—FINANCIAL INFORMATION

Item 1.

Financial Statements.

Index to Financial Statements

Unaudited Financial Statements for the Three and Nine Months Ended September 30, 2017
Balance Sheets	3
Statement of Operations	4
Statement of Changes in Net Assets	5
Statement of Cash Flows	6
Notes to Financial Statements	7

Index

LIFE PARTNERS POSITION HOLDER TRUST

BALANCE SHEETS

SEPTEMBER 30, 2017 and DECEMBER 31, 2016

	September 30, 2017		December 31, 2016
	(unaudited)
Assets
Cash	$	8,070,105	$	23,927,247
Maturity escrow held by third party		5,055,450		6,881,784
Maturities receivable		12,145,715		7,386,420
Premiums receivable, net		—		661,878
Prepaids and other assets		67,342		164,867
Restricted cash and cash equivalents		82,021,846		79,522,890
Life insurance policies		286,155,720		263,579,040
Total assets	$	393,516,178	$	382,124,126

Liabilities
Notes payable	$	94,067,102	$	94,010,671
Assumed tax liability		3,323,671		4,102,099
Creditor trust funding		5,000,000		10,000,000
Premium liability		31,126,592		25,776,263
Pre-effective maturity liabilities		15,154,369		38,026,076
Accounts payable		2,920,403		200,072
Assumed liabilities		334,797		5,741,922
Accrued expenses		1,394,557		517,469

Commitments and contingencies (Note 2)

Total liabilities	$	153,321,491	$	178,374,572

Net assets	$	240,194,687	$	203,749,554

Index

LIFE PARTNERS POSITION HOLDER TRUST

STATEMENT OF OPERATIONS

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2017

	Three Months Ended		Nine Months Ended
	(unaudited)		(unaudited)
Income
Change in fair value of life insurance policies	$	26,170,478	$	48,847,912
Total income		26,170,478		48,847,912

Expenses
Interest expense		1,805,161		5,422,804
Legal Fees		633,272		3,467,789
Professional Fees		1,420,133		2,779,448
Insurance		375		10,855
Other general and administrative		179,369		721,883

Total expenses		4,038,310		12,402,779

Net increase in net assets resulting from operations	$	22,132,168	$	$ 36,445,133

Index

LIFE PARTNERS POSITION HOLDER TRUST

STATEMENT OF CHANGES IN NET ASSETS

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2017

	Three Months Ended		Nine Months Ended
	(unaudited)		(unaudited)
Net assets, beginning of period	$	218,062,519	$	203,749,554
Net increase in net assets resulting from operations		22,132,168		36,445,133

Net assets, end of period	$	240,194,687	$	240,194,687

Index

LIFE PARTNERS POSITION HOLDER TRUST

STATEMENT OF CASH FLOWS

NINE MONTHS ENDED SEPTEMBER 30, 2017

	September 30, 2017
	(unaudited)
Cash flows from operating activities:
Net increase in net assets resulting from operations	$	36,445,133
Adjustments to reconcile net increase in net assets to net cash used in operations:
Change in fair value of life insurance policies		(48,847,912	)
Change in assets and liabilities:
Maturity escrow held by third party		1,826,334
Prepaids and other assets		97,525
Premiums receivable, net		661,878
Maturities receivable		(870,671	)
Assumed tax liability		(778,428	)
Pre-effective maturity liabilities		(22,871,707	)
Creditor trust funding		(5,000,000	)
Premiums payable		5,350,329
Accounts payable		2,720,331
Accrued expenses		933,519
Assumed liabilities		(5,407,125	)

Net cash flows used in operating activities		(35,740,794	)
Cash flows used in investing activities:
Contributed cash		—
Premiums paid on life insurance policies		(24,599,593	)
Proceeds from maturity of life insurance policies		46,982,201
Proceeds from issuance of notes payable		—
Payments on maturity funds facility		—
Net cash flows used in investing activities		22,382,608

Net (decrease) in cash		(13,358,186	)

Cash, beginning of period		103,450,137

Cash, end of period	$	90,091,951

Supplemental cash flow information:
Cash	$	8,070,105
Restricted cash and cash equivalents		82,021,846

Total cash	$	90,091,951
Supplemental cash flow information:
Cash paid for interest	$	3,403,128

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 1 - Operations and Significant Accounting Policies

Operations

Life Partners Position Holder Trust (the “Trust”) was created on December 9, 2016, pursuant to the Revised Third Amended Joint Plan of Reorganization of Life Partners Holdings, Inc., et al., dated as of October 27, 2016, which we call the “Plan,” that was confirmed by order of the United States Bankruptcy Court for the Northern District of Texas, Fort Worth Division on November 1, 2016. Life Partners Holdings, Inc. was the parent company of Life Partners, Inc., a Texas corporation, and its wholly-owned subsidiary LPI Financial Services, Inc., a Texas corporation (collectively, the “Debtors”). From 1991 until 2014, Life Partners, Inc. was a specialty financial services company engaged in the business of purchasing individual life insurance policies from third parties by raising money from the offer and sale to investors of “fractional interests” in such policies. LPI Financial Services, Inc. was organized to bill and collect certain fees charged to investors in connection with the business. Life Partners and LPI Financial Services also filed for protection under Chapter 11 of the Bankruptcy Code.

In connection with its formation and the inception of its activities on December 9, 2016, the Trust issued a total of 1,012,355,948 units of beneficial interest (the “Units”) to the fractional interest holders having claims in the Debtors bankruptcy pursuant to the Plan. Each fractional interest holder received a Unit for each dollar of expected death benefit such holder contributed to the Trust. As of September 30, 2017 and December 31, 2016, there were 10,386 and 12,243 holders of the 1,154,518,519 and 1,012,364,792 Units outstanding, respectively. The Trust owns a portfolio of life insurance policies; a portion of the policies is encumbered by the economic interest of continuing fractional interest holders. The Trust’s portion of the portfolio consists of 3,177 and 3,252 life insurance policies, with fair values of $286.2 million and $263.6 million and an aggregate face value of approximately $1.3 billion and $1.3 billion at September 30, 2017 and December 31, 2016, respectively. The fair value of the interests in the life insurance policies owned by continuing fractional interest holders are not reflected in the financial statements of the Trust.

Summary of Significant Accounting Policies

Basis of Presentation

The Trust’s primary purpose is the liquidation of the Trust’s assets and the distribution of proceeds to its beneficial interest holders. The Trust expects that fulfilling its purpose requires a significant amount of time, and that the Trust will have significant ongoing operations during that period due to the nature of its assets and its plan to maximize the proceeds to its beneficiaries by maintaining the majority of its life insurance policies until maturity. As a result, the Trust has concluded that its liquidation is not imminent, in accordance with the definitions under accounting principles generally accepted in the United States of America, and has not applied the liquidation basis of accounting in presenting its financial statements. The Trust will continue to evaluate its operations to determine when its liquidation becomes imminent and the liquidation basis of accounting is required.

Investments in Life Insurance Policies

The Trust accounts for its interests in life insurance policies at fair value in accordance with ASC 325-30, Investments in Insurance Contracts. The Trust initially recognized the life insurance policies transferred at its inception at their fair market value on December 9, 2016 and the Trust will estimate the fair value of its life insurance policies and recognize changes therein at each subsequent reporting period.

Fair Value of Life Insurance Policies

The Trust follows ASC 820, Fair Value Measurements and Disclosures, in estimating the fair value of its life insurance policies, which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability.

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 1 - Operations and Significant Accounting Policies - (Continued)

As a basis for considering such assumptions, the guidance establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Trust’s investments in life insurance policies are considered to be Level 3 as there is currently no active market where the Trust is able to observe quoted prices for identical assets and the Trust’s valuation model incorporates significant inputs that are not observable.

The Trust’s valuation of life insurance policies is a critical estimate within the financial statements. The Trust currently uses a probabilistic method of valuing life insurance policies, which the Trust believes to be the preferred valuation method in its industry. The Trust calculates the assets’ fair value using a present value technique to estimate the fair value of the projected future cash flows. The most significant assumptions in estimating the fair value are the Trust’s estimate of the insureds’ life expectancy and the discount rate. See Note 6, “Fair Value Measurements.”

Income Recognition

The Trust’s investments in life insurance policies are its primary source of income. Gain or loss is recognized from ongoing changes in the portfolio’s estimated fair value, including any gains or losses at maturity. Gains or losses from maturities are recognized at receipt of a death notice or verified obituary for an insured party, and determined based on the difference between the death benefit and the estimated fair value of the policy at maturity.

Premiums Receivable

The Trust assumed the Debtors’ receivables related to life insurance policy premiums and service fees that were paid by the Debtors on behalf of fractional interest holders prior to the Trust’s effective date. After December 9, 2016, the policy premiums allocable to continuing fractional interest holders are those persons' obligations and not the Trust. If a continuing fractional interest holder defaults on future premium obligations, such position is deemed contributed to the Trust in exchange for the number of Units provided by the Plan, as recently modified by the Bankruptcy Court

The Trust maintains an allowance for doubtful accounts for estimated losses resulting from the inability to collect premiums and service fees receivable. Such estimates are based on the position holder’s payment history and other indications of potential uncollectability. After all attempts to collect a receivable have failed, receivables are written off against the allowance. At September 30, 2017 and December 31, 2016, the allowance for doubtful accounts was $5.0 million, all of which was for receivables assumed from the Debtors on the effective date. Outstanding receivable balances may be recoverable pursuant to the Trustee’s set-off rights under the Plan.

Maturities Receivable

Maturities receivable consist of the Trust’s portion of life insurance policy maturities that occurred but payment was not yet received.

Income Taxes

No provision for state or Federal income taxes has been made as the liability for such taxes is attributable to the Unit holders rather than the Trust. The Trust is a grantor trust with taxable income or loss passing through to the Unit holders. In certain instances, however, the Trust may be required under applicable state laws to remit directly to state tax authorities amounts otherwise due to Unit holders. Such payments on behalf of the Unit holders are deemed distributions to them.

The Financial Accounting Standards Board (the “FASB”) has provided guidance for how uncertain tax positions should be recognized, measured, disclosed, and presented in the financial statements. This requires the

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 1 - Operations and Significant Accounting Policies - (Continued)

evaluation of tax positions taken or expected to be taken in the course of preparing the Trust’s tax returns to determine whether the tax positions are more-likely-than-not of being sustained when challenged or when examined by the applicable taxing authority. The Trust has no material uncertain income tax positions as of September 30, 2017 or December 31, 2016.

The Trust also assumed income tax liabilities of the Debtors at its inception which total approximately $2.9 million as of September 30, 2017 and December 31, 2016 related to taxes, penalties, and interest from the Debtors’ 2008, 2009 and 2010 income tax returns. These obligations bear interest at 4% annually and are due in full by January 2020.

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses primarily include professional services, legal fees and expected litigation settlements, some of which are obligations assumed by the Trust that were incurred prior to the effective date of the Trust. The Trust also accrues liabilities for state taxes payable and other miscellaneous accruals. The Trust accrues liabilities when costs are incurred and such costs can be reasonably estimated. Accrued expenses related to the Debtors’ bankruptcy are included in assumed liabilities on the accompanying balance sheet.

Creditors’ Trust Funding Liability

Pursuant to the Plan, in December 2016 and January 2017, the Trust contributed $2 million and $5 million respectively, to the Creditor’s Trust that was also established contemporaneously under the Plan. As of September 30, 2017, the Trust is obligated to fund an additional $5 million in January 2018.

Premium Liability

As of September 30, 2017 and December 31, 2016, the Trust holds $31.1 million and $25.8 million, respectively, in escrow for future payment of premium obligations. To the extent advanced premiums received from continuing fractional holders are not used for premium payments, they are refunded to the respective continuing fractional holder.

Pre-Effective Maturity Liabilities

On December 9, 2016, the Trust received funds related to maturities that occurred prior to the formation of the Trust. These funds are recognized as a liability on the accompanying balance sheet as pre-effective maturity liabilities owed to the fractional interest holders. Additionally, the Trust has recorded a receivable for maturities that occurred prior to December 9, 2016 where proceeds were not received as of that date. This receivable was $0 and $9.0 million as of September 30, 2017 and December 31, 2016 respectively and is included in pre-effective maturity liabilities on the accompanying balance sheet.

Use of Estimates

The preparation of these financial statements, in conformity with generally accepted accounting principles in the United States of America (“GAAP”), requires the Trust to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Actual results could differ from these estimates and such differences could be material. The estimates related to the valuation of the life insurance policies represent significant estimates made by the Trust.

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 1 - Operations and Significant Accounting Policies - (Continued)

Risks and Uncertainties

The Trust encounters economic, legal, and longevity risk. The two main components of economic risk potentially impacting the Trust are market risk and concentration of credit risk. The Trust’s market risks include interest rate risk and the risk of declines in valuation of the Trust’s life insurance policies, including declines caused by the selection of increased discount rates associated with the Trust’s fair value model. It is reasonably possible that future changes to estimates involved in valuing life insurance policies could change and result in material effects to the future financial statements. Concentration of credit risk is the risk that an insurance carrier who has issued life insurance policies held by the Trust, does not remit the amount due under those policies due to the deteriorating financial condition of the carrier or otherwise. Another credit risk potentially impacting the Trust is the risk continuing fractional holders may default on their future premium obligations, increasing the Trust’s premium liability.

There exists a legal risk courts would allow insurance carriers to retain premiums paid by the Trust in respect of insurance policies that are successfully rescinded or contested. In addition, our title or right to benefit from an insurance policy may be challenged by the insurer or the insured’s family.

Longevity risk refers to the reasonable possibility that actual mortalities of insureds in the Trust’s portfolio extend over longer periods than are anticipated, resulting in the Trust paying more for premiums.

The Trust maintains the majority of its cash in several accounts with a commercial bank. Balances on deposit are insured by the Federal Deposit Insurance Corporation (“FDIC”). However, from time to time the Trust's balances may exceed the FDIC insurable amount at its banks.

Description of Securities

Units represent beneficial interests in the Trust, and all holders of Units are entitled to receive cash distributions from the Trust in accordance with their respective Pro Rata shares. A Trust beneficiary’s respective “Pro Rata Share” means the ratio, expressed as a percentage, of (i) the number of Units which such Trust beneficiary is the registered owner, to (ii) the total number of Units outstanding as of the measurement date, subject to modification for purposes of distributing any recovered assets.

Initial units of Position Holder Trust Interest were issued on the basis of one (1) Unit for each $1 of death benefit payable (rounded to the nearest dollar) associated with the ownership of Fractional Positions. Subsequent issuances of Units will be issued to continuing fractional interest holders if they default on their premium payment obligations. Such Units will be issued in exchange for the defaulting position, in accordance with the basis and discounts delineated in the Plan, as recently modified by the Bankruptcy Court. Each Unit holder has the same rights with respect to each Unit as every other Unit holder.

Unit holders do not have any voting rights under the Position Holder Trust Agreement with respect to the appointment of any successor to the Trustee, filling any vacancy on the Governing Trust Board or any action to be taken by the Position Holder Trust, including without limitation whether the duration of the Trust should be extended after the end of the initial 10-year term. Unit holders have no liability for the debts and other obligations of the Position Holder Trust and bear no expenses in connection with the organization and administration of the Trust. The Trust is a pass-through tax entity and its Unit holders may be allocated taxable income without a matching cash distribution, leading to an unfunded tax obligation. The Trust has the right, but not the obligation, to offset against any distributions allocated to any Unit holder in an amount equal to all unpaid amounts owed by the holder, including all unpaid amounts owed for catch-up payments, pre-petition default amounts and post-effective date payment defaults.

Under the Plan, the Trustee will distribute at least annually to the Unit holders all of the distributable cash (as defined in the Position Holder Trust Agreement) generated during each calendar year, subject to any reserve established by the Trustee reasonably necessary to maintain the value of the Registrant’s assets or to meet claims and contingent liabilities. All distributions by the Trust will be made in accordance with such holder’s Pro Rata share of the outstanding Units.

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 1 - Operations and Significant Accounting Policies - (Continued)

Continuing Fractional Interests

The continuing fractional interest of a fractional interest holder who made a continuing holder election will represent 95% of the beneficial ownership associated with the Fractional Interest with respect to which the Election was made, with the other 5% comprising the Continuing Position Holder Contribution made to the Position Holder Trust on the Effective Date. The continuing fractional interest holder (“CFH”) is obligated to pay 95% of the premium payments and policy expenses allocable to the fractional interest. Upon maturity of a Policy, the CFH with positions in the Policy will be entitled to receive the Policy proceeds allocable to each such continuing fractional interest held. The Policy proceeds paid to a CFH will be reduced by (1) the servicing fee payable with respect to each such continuing fractional interest, and (2) any premium amount paid by the Trust prior to the date of death with respect to the continuing fractional interest that is not refunded as a result of the maturity.

Upon the occurrence of a payment default with respect to a continuing fractional interest, the CFH will be deemed to have contributed the position to the Trust at a discount of 20%, effective as of the payment default date.

Recently Issued Accounting Pronouncements

In November 2016, the FASB issued guidance under the Account Standards Update (“ASU”) 2016-18, Statement of Cash Flows: Restricted Cash, which provides guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flows. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. The Trust elected to adopt this provision early, and this adoption did not have a material impact on the Trust’s financial statements.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers,” which converges the FASB and the International Accounting Standards Board (“IASB”) standard on revenue recognition. Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. In April 2015, the FASB voted to defer the effective date of the new revenue recognition standard by one year. As a result, the provisions of this ASU are now effective for interim and annual periods beginning after December 15, 2017. The Trust does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows.

Note 2 - Commitments and Contingencies

Litigation

In accordance with applicable accounting guidance, the Trust establishes an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. In such cases, there may be an exposure to loss in excess of any amounts accrued. When a loss contingency is not both probable and estimable, the Trust does not establish an accrued liability. As a litigation or regulatory matter develops, the Trust, in conjunction with any outside counsel handling the matter, evaluates on an ongoing basis whether such matter presents a loss contingency that is probable and estimable. If, at the time of evaluation, the loss contingency related to a litigation or regulatory matter is not both probable and estimable, the matter will continue to be monitored for further developments that would make such loss contingency both probable and estimable. When a loss contingency related to a litigation or regulatory matter is deemed to be both probable and estimable, the Trust will establish an accrued liability with respect to such loss contingency and record a corresponding amount of litigation-related expense. The Trust will then continue to monitor the matter for further developments that could affect the amount of any such accrued liability.

Indemnification of Certain Persons

Under certain circumstances, the Trust may be required to indemnify certain persons performing services on behalf of the Trust for liability they may incur arising out of the indemnified persons' activities conducted on

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 2 - Commitments and Contingencies (Continued)

behalf of the Trust. There is no limitation on the maximum potential payments under these indemnification obligations and, due to the number and variety of events and circumstances under which these indemnification obligation could arise, the Trust is not able to estimate such maximum potential payments. The Trust has not made any payments under such indemnification obligations and no amount has been accrued in the accompanying financial statements for these indemnification obligations of the Trust.

Note 3 - Restricted Cash and Cash Equivalents

The Plan imposes restrictions on the Trust to maintain certain funds in segregated accounts. As of September 30, 2017 and December 31, 2016, the Trust has approximately $7.7 million and $26.2 million, respectively, in the pre-effective maturity escrow account which are distributable to the fractional interest holders in those policies that matured prior to the Plan becoming effective. The Plan further requires the Trust to maintain certain reserves in segregated accounts; as of September 30, 2017 and December 31, 2016, those reserves were approximately $44.4 million and $27.5 million, respectively. The Trust also maintains escrow accounts on behalf of the continuing fractional interest holders from which to fulfill their premium obligations; as of September 30, 2017 and December 31, 2016, the Trust held approximately $29.9 million and $25.8 million, respectively, on their behalf. See Note 1, “Premium Liability.”

Note 4 - Life Insurance Policies

As of September 30, 2017, the Trust owns an interest in 3,177 policies of which 620 are life settlement policies and 2,577 are viaticals (the “PHT Portfolio”). The PHT Portfolio’s aggregate face value is $1.3 billion as of September 30, 2017 of which $1.1 billion is attributable to life settlements and $180.4 million is attributable to viaticals. The PHT Portfolio’s aggregate fair value is $286.2 million as of September 30, 2017 of which $283.7 million is attributable to life settlements and $2.5 million is attributable to viaticals. The weighted average life expectancy calculated based on the fair value of the death benefit of insureds in the policies owned by the Trust at September 30, 2017 was 3.6 years.

As of December 31, 2016, the Trust owned an interest in 3,252 policies of which 654 are life settlement policies and 2,598 are viaticals (the “PHT Portfolio”). The PHT Portfolio’s aggregate face value is $1.3 billion as of December 31, 2016 of which $1.1 billion is attributable to life settlements and $191.2 million is attributable to viaticals. The PHT Portfolio’s aggregate fair value is $263.6 million as of December 31, 2016 of which $261.6 million is attributable to life settlements and $2.0 million is attributable to viaticals. The weighted average life expectancy calculated based on the fair value of the death benefit of insureds in the policies owned by the Trust at December 31, 2016 was 4.0 years.

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 4 - Life Insurance Policies - (Continued)

Life expectancy reflects the probable number of years remaining in the life of a class of persons determined statistically, affected by such factors as heredity, physical condition, nutrition, and occupation. It is not an estimate or an indication of the actual expected maturity date or indication of the timing of expected cash flows from death benefits. See “Life Insurance policies,” in Note 6, “Fair Value Measurements.” The following tables summarizes the Trust's life insurance policies grouped by remaining life expectancy as of September 30 ,2017 and December 31, 2016:

As of September 30, 2017:

Remaining Life Expectancy (Years)	Number of Life Insurance Policies		Face Value		Fair Value
0-1		25	$	56,207,688	$	43,884,176
1-2		44		69,880,054		42,137,638
2-3		64		81,805,300		35,859,153
3-4		57		87,802,823		28,775,972
4-5		108		181,159,206		42,876,670
Thereafter		2,879		807,373,873		92,622,111

Total		3,177	$	1,284,228,944	$	286,155,720

As of December 31, 2016:

Remaining Life Expectancy (Years)	Number of Life Insurance Policies		Face Value		Fair Value
0-1		19	$	26,906,072	$	22,344,600
1-2		29		59,109,822		38,672,708
2-3		60		53,027,573		26,251,734
3-4		59		95,930,412		35,577,890
4-5		86		112,725,236		29,193,315
Thereafter		2,999		942,298,899		111,538,793

Total		3,252	$	1,289,998,014	$	263,579,040

Estimated premiums to be paid by the Trust for its portfolio during each of the five succeeding fiscal years and thereafter as of September 30, 2017, are as follows:

2017	$	9,852,086
2018		43,706,522
2019		50,208,934
2020		51,169,045
2021		46,980,546
Thereafter		207,370,714

Total	$	409,287,847

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 4 - Life Insurance Policies - (Continued)

The amount of $409.3 million represents the estimated total future premium payable by the Trust. The Trust is required to pay its portion to keep the life insurance policies in force during the life expectancies of all the underlying insured lives. The estimated total future premium payments could increase or decrease significantly to the extent that insurance carriers increase the cost of insurance on their issued policies or that actual mortalities of insureds differs from the estimated life expectancies. If the continuing fractional holders default on their future premium obligations, the Trust’s premium liability may increase.

The Trust anticipates funding the estimated premium payments from maturities of life insurance policies. It also maintains premium reserves and access to lines of credit.

Note 5 - Notes Payable

On December 9, 2016, the Trust obtained a term loan from Vida Opportunity Fund, LP, an affiliate of Vida Capital, Inc., for $55.0 million. Interest accrues at 11% of outstanding balance per annum and is paid quarterly. Principal is due in full on December 9, 2018, but is not subject to a prepayment penalty. Substantially all of the Trust’s assets collateralize the loan. As of September 30, 2017 and December 31, 2016, the outstanding balance was $55.0 million.

On December 9, 2016, the Trust entered into a revolving line of credit with Vida Longevity Fund, LP, an affiliate of Vida Capital, Inc., for $25.0 million. Interest accrues at 11% of outstanding balance and is paid quarterly. The line of credit matures on December 9, 2018, at which point any amount outstanding is due in full. As of September 30, 2017 and December 31, 2016, no amounts have been drawn on the line of credit.

In accordance with the Plan, the Trust issued notes totaling approximately $36.5 million in exchange for claims against the Debtor’s estate and the incidental interests in life insurance policies. Those policies collateralize the Trust’s obligations under the notes. Interest accrues at 3% of outstanding balance and is paid annually in December. Principal is due in full on December 9, 2031. In accordance with the note, beginning in December 2017, the Trust is required to make annual payments to a sinking fund to pay future interest and principal. As of September 30, 2017 and December 31, 2016, the outstanding balance of the notes was $36.5 million.

On March 28, 2017, the Trust, was ordered to pay the Chapter 11 trustee’s fees totaling $5.5 million. The first payment of $2.8 million was due promptly after the Court order and is included in accounts payable on the accompanying statement of assets and liabilities as of December 31, 2016. The remaining balance is in the form of a note payable in the amount of $2.8 million and is due in three equal annual payments on January 1 beginning in 2019. The note does not bear interest as ordered by the Court, thus the note has been discounted by $0.2 million, based on an implied interest rate of 3% as of December 31, 2016. As of September 30, 2017 and December 31, 2016, the outstanding balance was $2.6 million.

Future scheduled principal payments on the above notes payable and required sinking fund contributions are as follows as of September 30, 2017:

	Sinking Fund		Notes Payable
2017	$	2,432,886	$	—
2018		2,432,886		55,000,000
2019		2,432,886		916,667
2020		2,432,886		916,667
2021		2,432,886		916,666
Thereafter		24,328,868		36,493,298
	$	36,493,298	$	94,243,298

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 6 - Fair Value Measurements

The Trust carries its life insurance policies at fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

Fair value measurements are classified based on the following fair value hierarchy:

Level 1 - Valuation is based on unadjusted quoted prices in active markets for identical assets and liabilities that are accessible at the reporting date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

Level 2 - Valuation is determined from pricing inputs that are other than quoted prices in active markets that are either directly or indirectly observable as of the reporting date. Observable inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and interest rates and yield curves that are observable at commonly quoted intervals.

Level 3 - Valuation is based on inputs that are both significant to the fair value measurement and unobservable. Level 3 inputs include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value generally require significant management judgment or estimation.

The balances of the Trust's assets measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016, are as follows:

As of September 30, 2017:

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Investment in life insurance policies	$	—	$	—	$	286,155,720	$	286,155,720
	$	—	$	—	$	286,155,720	$	286,155,720

As of December 31, 2016:

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Investment in life insurance policies	$	—	$	—	$	263,579,040	$	263,579,040
	$	—	$	—	$	263,579,040	$	263,579,040

Quantitative Information about Level 3 Fair Value Measurements

Fair Value at

9/30/2017

Face value at

9/30/2017

Valuation

Technique(s)

Unobservable

Inputs

Range

(Weighted Average)

Life insurance policies

286,155,720

1,284,228,944

Discounted cash flow

Discount rate

25.2%-31.7

Life expectancy evaluation

3.6 years

		Fair Value at 12/31/16				Face value at 12/31/16			Valuation Technique(s)		Unobservable Inputs		Range (Weighted Average)
Life insurance policies		$	263,579,040			$	1,289,998,014		Discounted cash flow		Discount rate			24.7%-31.7	%

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 6 - Fair Value Measurements - (Continued)

Fair Value at 12/31/16	Face value at 12/31/16	Valuation Technique(s)	Unobservable Inputs	Range (Weighted Average)

			Life expectancy evaluation	4.0 years

Following is a description of the methodologies used to estimate the assets’ fair value measured on a recurring basis and within the above fair value hierarchy.

The Portfolio was valued using a probabilistic approach, which is actuarially based. This approach fits the Portfolio’s cash flows (premium payments and death benefits) to a monthly mortality scale as generated by each insured’s specific life expectancy. This mortality scale is actuarially rolled forward from the life expectancy underwriting date to the valuation date. This mathematical approach is substantially the same as actuaries customarily use in the pricing of life insurance and annuities. The Trust discounted the monthly cash flows with interest and survivorship back to the valuation date of as of September 30, 2017 and December 31, 2016, to arrive at the Portfolio’s estimated value.

The valuations presented here are net of a 2.65% servicing fee payable under the Plan. The Trust utilized each Policy’s “optimized” premium. The Trust relied on life expectancy values provided by its servicing company that were in turn provided to it from qualified industry experts. If a particular Policy did not have a life expectancy, the Trust used the Society of Actuaries’ 2015 Valuation Basic Tables, smoker distinct mortality tables developed by the U.S. Society of Actuaries (the “2015 VBT”) to obtain the average probability of death for similarly categorized persons and applied mortality multipliers by type/gender, to arrive at an estimated life expectancy for the insured. The mortality multipliers used are: 100% for the life settlement males, 100% for the life settlement females and 350% for the viaticals regardless of gender. The 2015 VBT are created based on the expected rates of death among different groups categorized by factors such as age and gender.

If the insured dies earlier than expected, the return will be higher than if the insured dies when expected or later than expected. The Trust’s estimates allow for the possibility that if the insured dies earlier than expected, the premiums needed to keep the policy in force will not have to be paid. Conversely, the calculation also considers the possibility that if the insured lives longer than expected, more premium payments will be necessary.

Life expectancy estimates are a significant input in the fair value determination. Future changes in the life expectancy estimates could have a material effect on the Portfolio’s fair value, which could have a material effect on its financial condition and results of operations. Life expectancy estimates for insureds over the age of 90 years are less reliable than estimates for younger persons, due to the relative lack of statistical information as to the health and mortality expectations for those over the age of 90 years. Accordingly, there is a correspondingly lower statistical basis for relying on life expectancy estimates based on medical underwriting for insureds in that age group. In addition, the average probability of death calculated in the 2015 VBT for those 90 years or older has less statistical reliability than the average probability of death calculations for younger persons. Nevertheless, the majority of industry participants continue to rely on medical underwriting and the 2015 VBT for all age ranges, including 90 and over. As the average age of the insureds for the life settlements in the Portfolio is 89 years, the Trust will continue to evaluate its ongoing reliance on the 2015 VBT and life expectancies based on medical underwriting and make adjustments to its underlying assumptions as actuarial knowledge regarding this population advances.

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 6 - Fair Value Measurements - (Continued)

Life expectancy sensitivity analysis

The table below reflects the effect on the PHT Portfolio’s fair value if the actual life expectancy experienced is 5% less or 5% more than is currently estimated. If the life expectancy estimate increases by 5% or decreases by 5%, the change in estimated fair value of the life insurance policies as of September 30, 2017 and December 31, 2016 would be as follows:

As of September 30, 2017 Life Expectancy Months Adjustment	Average life expectancy	Value		Change in Value
- 5%		$	301,220,686	$	15,064,966
No change	3.6 years	$	286,155,720	$	—
+ 5%		$	271,624,213	$	(14,531,507	)

As of December 31, 2016 Life Expectancy Months Adjustment	Average life expectancy	Value		Change in Value
- 5%		$	277,276,497	$	13,697,457
No change	4.0 years	$	263,579,040	$	—
+ 5%		$	249,069,410	$	(14,509,630	)

Discount rate

The discount rate is another significant input in the fair value determination. The Trust’s estimate incorporates market factors, the size of the portfolio, and various policy specific quantitative and qualitative factors including known information about the underlying insurance policy, its economics, the insured and the insurer.

The effect of changes in the weighted average discount rate on the death benefit and premiums used to estimate the PHT Portfolio’s fair value has been analyzed. If the weighted average discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of September 30, 2017 and December 31, 2016 would be as follows:

As of September 30, 2017 Rate Adjustment	Value		Change in Value
+2%	$	273,359,032	$	(12,796,688	)
No change	$	286,155,720	$	—
-2%	$	300,310,106	$	14,154,386

As of December 31, 2016 Rate Adjustment	Value		Change in Value
+2%	$	250,218,915	$	(13,360,125	)
No change	$	263,579,040	$	—
-2%	$	278,442,322	$	14,863,282

Future changes in the discount rates used by the Trust to value life insurance policies could have a material effect on the Trust's yield on life settlement transactions, which could have a material adverse effect on the Trust’s financial condition and results of operations.

The Trust re-evaluates its discount rates at the end of every reporting period in order to estimate the discount rates that could reasonably be used by market participants in a transaction involving the Trust's life insurance policies. In doing so, the Trust engages third party consultants to corroborate its assessment, engages in discussions with other market participants and extrapolates the discount rate underlying actual sales of insurance policies.

Index

LIFE PARTNERS POSITION HOLDER TRUST

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2017

(unaudited)

Note 6 - Fair Value Measurements - (Continued)

Credit Exposure to Insurance Companies

The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit or 10% of total fair value of the Trust's life insurance policies as of September 30, 2017:

Carrier	Percentage of Face Value			Percentage of Fair Value			Carrier Rating
The Lincoln National Life Insurance		11.3	%		14.1	%		A	+
John Hancock Life Insurance (USA)		7.5	%		11.4	%		A	+
Transamerica Financial Life Insurance		9.1	%		11.1	%		A	+

Changes in Fair Value

The following table provides a roll-forward in the changes in fair value for the three and nine months ended September 30, 2017, for the Trust’s life insurance policies:

	Three months ended (unaudited)			Nine months ended (unaudited)
Beginning balance	$	273,147,684		$	263,579,040
Change in fair value		26,170,479			48,847,913
Matured policies, net of fees		(19,344,711	)		(50,870,826	)
Premiums paid		6,182,269			24,599,593

Ending balance	$	286,155,720		$	286,155,720

Changes in fair value included in earnings for the period relating to assets held at September 30, 2017	$	9,480,259		$	5,973,378

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion in conjunction with the consolidated financial statements and accompanying notes and the information contained in other sections of this report. The statements in this discussion and analysis concerning expectations regarding the Position Holder Trust’s future performance, liquidity and capital resources, as well as other non-historical statements in this discussion and analysis, are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those described above under “Cautionary Statement Regarding Forward-Looking Statements,” included in the Trust’s Form 10 Registration Statement (File No. 000-55783), which are incorporated herein by reference. The actual results of the Trust could differ materially from those suggested or implied by any forward-looking statements.

Business Overview

The Position Holder Trust and the IRA Partnership came into existence on December 9, 2016, as a result of the Plan of Reorganization confirmed pursuant to the Chapter 11 bankruptcy proceeding initiated in 2015 by Life Partners Holdings, Inc. At the time of its establishment by the Bankruptcy Court, the Portfolio’s primary asset was a life insurance portfolio of 3,252 policies, with an aggregate fair value of $470.7 million and an aggregate face value of approximately $2.2 billion at December 31, 2016. The Trust’s portion of the Portfolio had a fair value of $263.6 million and a face value of $1.3 billion at December 31, 2016. Adjustments in the calculation of the aggregate fair value of the Portfolio may occur over time as maturities ensue in the Portfolio and life expectancies change.

The Bankruptcy Court organized the Trust and the IRA partnership in order to liquidate the assets of the Debtors in a manner calculated to conserve, protect and maximize the value of the assets, and to distribute the proceeds thereof to the Trust’s securities holders in accordance with the Plan. The Trust and IRA Partnership have no other business interests nor operations and will not acquire any additional life insurance policies in the future. The Trust’s beginning assets and liabilities were contributed pursuant to the Plan as of December 9, 2016.

Index

Results of Continuing Operations

Three and Nine Months Ended September 30, 2017

The Position Holder Trust’s net income from operations for three and nine months ended September 30, 2017 was $22.1 and $36.4 million, respectively. The Trust recognizes income on its respective portion of the Policies primarily from changes in their aggregate fair value. The Trust did not exist before December 9, 2016, so there is no comparable 2016 financial information. There was no tax expense nor benefit for the three and nine month period ended September 30, 2017. The following is the analysis of net income for the three and nine month period ended September 30, 2017:

	Three months ended (unaudited)			Nine months ended (unaudited)
Income	$	26,170,478		$	48,847,912
Expense		(4,038,310	)		(12,402,779	)
Net increase in net assets resulting from operations	$	22,132,168		$	36,445,133

The following table provides a roll-forward in the changes in fair value for the three and nine month period ended September 30, 2017, for the PHT Portfolio life insurance policies:

	Three months ended (unaudited)			Nine months ended (unaudited)
Beginning balance	$	273,147,684		$	263,579,040
Change in fair value		26,170,479			48,847,913
Matured policies, net of fees		(19,344,711	)		(50,870,826	)
Premiums paid		6,182,269			24,599,593

Ending balance	$	286,155,720		$	286,155,720

Changes in fair value included in earnings for the period relating to assets held at September 30, 2017	$	9,480,259		$	5,973,378

The change in underlying fair values of the assets from the Debtors to the asset values determined for the Policies reflects updated life expectancies procured by the Trust in respect of the insured lives and maturities during the period.

As of September 30, 2017, the total Portfolio held 3,177 Policies with an estimated fair value of $498.5 million compared to 3,252 policies with a fair value of $470.7 million at December 31, 2016, an increase of $27.8 million or 5.9%. Of the 3,177 Policies’ estimated fair value of $498.5 million, $286.2 million is attributable to the PHT Portfolio and $212.3 million to the Continuing Fractional Holders. As of September 30, 2017, the Policies’ aggregate death benefit was approximately $2.1 billion, which was comprised of $1.9 billion in life settlement contracts and $254.9 million in viatical contracts.

The 3,177 Policies owned as of September 30, 2017, were valued using a base or foundational discount rate of 15%, with further valuation adjustments based upon the size of the insured pool, life expectancy data, distinctions between life settlement and viatical policies and whether the Policies are whole life, convertible term or non-convertible term policies and with a post-adjustment weighted average discount rate of 25.2% See Note 6, "Fair Value Measurements," to the accompanying consolidated financial statements. There were no Policy sales during three-month period ended September 30, 2017.

Interest expense for the three and nine months ended September 30, 2017 primarily consisted of $1.5 million and $4.6 million on the Vida loan, respectively, and $0.3 million and $0.8 million on the New IRA Notes payable, respectively.

Investing Activities

During the three and nine months ended September 30, 2017, the Position Holder Trust paid premiums of $6.2 million and $24.6 million, respectively, on the PHT Portfolio.

Index

During the three and nine months ended September 30, 2017, the Trust received $0 and $22.1 million respectively of premiums in advance of their due date from the CFH. Advanced premiums received from the CFH are held in restricted cash until paid to the insurance companies. The Trust paid premiums to insurance carriers on behalf of the CFH of $2.3 million and $13.6 million during the three and nine months ended September 30, 2017, respectively. To the extent advanced premiums received from the CFH are not used for premium payments due to maturities, they are refunded. During the three and nine months ended September 30, 2017, the Trust refunded $2.4 million to the CFH.

Financing Activities

The Position Holder Trust did not engage in any financing activities during the three nor nine month period ended September 30, 2017.

Continuing Operations

While the Position Holder Trust is a liquidating trust with no intent to continue or engage in a trade or business, the nature of the life insurance policies assets being liquidated are such that it is not practical or advantageous to simply liquidate the Policies by disposing of them; there is no viable secondary market for the Policies, nor is there another practical means of disposing of them or monetizing them in the near term.

The Trust expects that fulfilling its purpose requires a significant amount of time, and that the Trust will have significant ongoing operations during that period due to the nature of its assets and its plan to maximize the proceeds to its beneficiaries by maintaining the majority of its life insurance policies until maturity. As a result, the Trust has concluded that its liquidation is not imminent, in accordance with the definitions under accounting principles generally accepted in the United States of America, and has not applied the liquidation basis of accounting in presenting its financial statements. The Trust will continue to evaluate its operations to determine when its liquidation becomes imminent and the liquidation basis of accounting is required.

Off-Balance Sheet Arrangements

As of September 30, 2017, the Position Holder Trust and IRA Partnership had no off-balance sheet arrangements.

Liquidity and Capital Resources

Vida Opportunity Fund, LP, an affiliate of Vida Capital, Inc. provided the $55 million Exit Loan Facility necessary to provide for consummation of the reorganization transactions contemplated by the Plan. Vida Longevity Fund, LP, also an affiliate of Vida Capital, Inc., provided a $25 million revolving line of credit. The obligations are secured by liens on virtually all of the Position Holder Trust’s assets.

The Plan authorizes the Trustee to use the Maturity Funds Facility to borrow, from time to time, on a short-term revolving basis to fund its premium reserves. The Position Holder Trust is also entitled to access the cash surrender value included in the beneficial ownership registered in its name from time to time to use for any purpose permitted by the Position Holder Trust Agreement, including to satisfy its share of the premium obligations relating to the Policies. If any such use results in a decrease in the death benefit payable under the related Policy, the decrease will reduce the Trust’s share of the maturity proceeds of the Policy, or if the Trust’s share is insufficient, it must make up the difference.

At September 30, 2017, the Trust had $90.1 million of cash available. Of this amount, $3.5 million was held to pay policy premiums, $29.9 million was held to pay for premiums collected and due on behalf of the CFH, $7.7 million was held to pay the outstanding pre-effective date maturities collected and owed to the CFH, and $0.8 million was available to pay for operating expenses of the Trust. The Trust believes that these financial resources are sufficient for it to continue its operations and to issue funds, as necessary, throughout the twelve months after the date of this report.

The Trust’s total outstanding liabilities were $153.3 million at September 30, 2017 a decrease of $6.8 million from $160.1 million at June 30, 2017, and a decrease of $25.1 million from $178.4 million at December 31, 2016. The decrease was mainly attributable to the expenditure of cash to pay outstanding liabilities associated with the payout of funds related to Pre-Effective Date Maturities, premium liability payments, and certain other obligations.

The Position Holder Trust’s primary needs for working capital are to pay premiums on policies and expenses relating to administration of the Trust and its assets. Pursuant to the Servicing Agreement, fees for servicing the policies will be paid out of the death benefits paid on policies in an amount equal to 2.65% of the death benefits paid. In addition, the Trust is required by the Plan to contribute $12 million to the Creditors’ Trust over the three-year period following the Effective Date. An initial $2 million was contributed to the Creditors’ Trust on December 9, 2016, and an additional $5 million was contributed on January 23, 2017.

Outstanding debt for the year ended December 31, 2016, included $55.0 million of outstanding principal on the Exit Loan Facility, $36.5 million of New IRA Notes, and $2.6 million to Thomas Moran.

Index

New IRA Notes

The Debtors’ estate included 1,177 security holders who held their positions through their individual retirement accounts. Pursuant to the U.S. Internal Revenue Code of 1986, life insurance contracts are prohibited investments for an IRA. As a result, the Plan includes mechanisms to resolve the IRA investors’ claims by establishing the IRA Partnership and authorizing the issuance of the New IRA Notes.

The Plan authorized the Position Holder Trust to issue New IRA Notes in a principal amount of up to $63.7 million bearing interest at the rate of 3.0% per annum, due 2031. The Trust agreed to pay the principal of and interest on the New IRA Notes on the dates and in the manner provided by the Indenture under which they were issued. As of September 30, 2017, the outstanding amount of the New IRA Notes was $36.5 million, with accrued interest of $0.8 million through September 30, 2017. Interest is payable annually commencing on December 15, 2017.

If the Trust elects to redeem any New IRA Notes, it must notify the New IRA Note trustee of the redemption date and the principal amount to be redeemed at least 60 days before the redemption date (unless a shorter period is satisfactory to the trustee). If fewer than all the New IRA Notes are being redeemed, the notice must also specify a record date not less than 15 days after the date of the notice of redemption is given to the New IRA Note trustee. The New IRA Note trustee will select the notes to be redeemed on a pro rata basis in denominations of $100 principal amount and higher integral multiples of $100.

Notes Payable per Order of the Bankruptcy Court

On March 28, 2017, the Bankruptcy Court’s allowed $5.5 million as reasonable compensation for the services rendered by H. Thomas Moran as Chapter 11 Trustee. The Court ordered the Position Holder Trust to pay 50%, or $2.8 million, promptly, which occurred March 30, 2017. The remaining $2.8 million is to be paid in cash pursuant to the terms of an unsecured promissory note issued by the Trust. The note does not bear interest and the principal amount will be paid in three equal annual installments on January 1 of 2019, 2020 and 2021, with the full principal amount paid no later than December 30, 2021, or in full on or after January 1, 2019.

Life Partners IRA Holder Partnership, LLC

As recognized by the bankruptcy court and described in section 27.02 of the Plan, the interests of the holders of the IRA Partnership are inextricably intertwined with those of the Position Holder Trust and the CFH, and accordingly, the financial reporting for the Position Holder Trust includes all material information that a standalone report the IRA Partnership would provide. Life Partners IRA Holder Partnership, LLC held interests in 731,317,865 Units as of September 30, 2017 and December 31, 2016 of the total number of Units of the Life Partners Position Holder Trust outstanding of 1,154,518,519 and 1,012,364,792 as of September 30, 2017 and December 31, 2016, respectively. The following tables present the IRA Partnership’s unaudited Balance Sheets, Statement of Operations and Statement of Changes in Net Assets for the three and nine months ended September 30, 2017:

BALANCE SHEET

SEPTEMBER 30, 2017 and DECEMBER 31, 2016

	September 30, 2017			December 31, 2016
	(unaudited)			(unaudited)
Assets
Investment in Life Partners Position Holder Trust		$	152,148,849		$	147,185,767
Total assets		$	152,148,849		$	147,185,767

Net assets		$	152,148,849		$	147,185,767

Index

STATEMENT OF OPERATIONS – THREE AND NINE MONTHS

ENDED SEPTEMBER 30, 2017

	Three months ended		Nine months ended
	(unaudited)		(unaudited)
Income
Increase in assets resulting from operations		1,251,750		4,963,082

Net increase in net assets	$	1,251,750	$	4,963,082

STATEMENT OF CHANGES IN NET ASSETS – THREE AND NINE MONTHS

ENDED SEPTEMBER 30, 2017

	Three months ended		Nine months ended
	(unaudited)		(unaudited)
Net assets, beginning of period	$	150,897,099	$	147,185,767

Increase in assets resulting from operations		1,251,750		4,963,082

Net assets, end of period	$	152,148,849	$	152,148,849

Critical Accounting Policies

Basis of Presentation

The Position Holder Trust’s primary purpose is the liquidation of the Trust’s assets and the distribution of proceeds to its beneficiaries. The Trust expects that fulfilling its purpose requires a significant amount of time, and that the Trust will have significant ongoing operations during that period due to the nature of its assets and its plan to maximize the proceeds to its beneficiaries by maintaining the majority of its life insurance policies until maturity. As a result, the Trust has concluded that its liquidation is not imminent, in accordance with the definitions under accounting principles generally accepted in the United States of America, and has not applied the liquidation basis of accounting in presenting its financial statements. The Trust will continue to evaluate its operations to determine when its liquidation becomes imminent and the liquidation basis of accounting is required.

Investments in Life Insurance Policies

Fair Value of Life Insurance Policies

Index

The Trust’s valuation of life insurance policies is a critical estimate within the financial statements. The Trust currently uses a probabilistic method of valuing life insurance policies, which the Trust believes to be the preferred valuation method in the industry. The Trust calculates the assets’ fair value using a present value technique to estimate the fair value of the projected future cash flows. The most significant assumptions in estimating the fair value are the Trust’s estimate of the insureds’ life expectancy and the discount rate. See Note 6, “Fair Value Measurements.”

Income Recognition

Premiums receivable

The Trust assumed the Debtor’s receivables related to life insurance policy premiums and service fees that were paid by the Debtors on behalf of fractional interest holders prior to the Trust’s effective date. After December 9, 2016, the policy premiums allocable to the CFH are those persons’ obligations and not the Trust’s. If a CFH defaults on future premium obligations, such position is deemed contributed to the Trust in exchange for the number of Units provided by the Plan.

The Trust maintains an allowance for doubtful accounts for estimated losses resulting from the inability to collect premiums and service fees receivable. Such estimates are based on the position holder’s payment history and other indications of potential uncollectability. After all attempts to collect a receivable have failed, receivables are written off against the allowance. At September 30, 2017 and December 31, 2016, the allowance for doubtful accounts totals $5.0 million, all of which was for receivables assumed from the Debtors on the Effective Date. Outstanding receivable balances may be recoverable pursuant to the Trustee’s set-off rights under the Plan.

Maturities receivable

Maturities receivable consist of the Trust’s portion of life insurance policy maturities that occurred but payment was not received as of September 30, 2017 and December 31, 2016.

Income Taxes

The Financial Accounting Standards Board (“FASB”) has provided guidance for how uncertain tax positions should be recognized, measured, disclosed, and presented in the financial statements. This requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Trust’s tax returns to determine whether the tax positions are more-likely-than-not of being sustained when challenged or when examined by the applicable taxing authority. The Trust has no material uncertain income tax positions as of September 30, 2017.

The Trust also assumed income tax liabilities of the Debtors at its inception which total approximately $2.9 million as of December 31, 2016, related to taxes, penalties, and interest from the Debtors’ 2008, 2009 and 2010 income tax returns. These obligations bear interest at 4% annually and are due in full by January 2020.

Use of Estimates

The preparation of these financial statements in conformity with GAAP, requires the Trust to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Actual results could differ from these estimates and such differences could be material. The estimates related to the valuation of the life insurance policies represent significant estimates made by the Trust.

Risks and Uncertainties

Index

interest rate risk and the risk of declines in valuation of the Trust’s life insurance policies, including declines caused by the selection of increased discount rates associated with the Trust’s fair value model. It is reasonably possible that future changes to estimates involved in valuing life insurance policies could change and result in material effects to the future financial statements. Concentration of credit risk is the risk that an insurance carrier who has issued life insurance policies held by the Trust, does not remit the amount due under those policies due to the deteriorating financial condition of the carrier or otherwise. Another credit risk potentially impacting the Trust is the risk continuing fractional holders may default on their future premium obligations, increasing the Trust’s premium liability.

There exists a legal risk that courts would allow insurance carriers to deny paying benefits and retain premiums paid by the Trust in respect of insurance policies that are successfully rescinded or contested. In addition, our title or right to benefit from an insurance policy may be challenged by the insurer or the insured’s family.

The Trust maintains the majority of its cash in several accounts with a commercial bank. Balances on deposit are insured by the Federal Deposit Insurance Corporation (“FDIC”); although the Trust’s balances may exceed the FDIC insurable amount at its banks.

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses primarily include professional services, legal fees and expected litigation settlements, some of which are obligations assumed by the Trust that were incurred prior to the Effective Date. The Trust also accrues liabilities for state taxes payable and other miscellaneous accruals. The Trust accrues liabilities when costs are incurred and such costs can be reasonably estimated. Accrued expenses related to the Debtor’s bankruptcy are included in assumed liabilities on the accompanying balance sheet.

Creditors’ Trust Funding Obligation

Pursuant to the Plan, in December 2016 the Trust contributed $2 million to the Creditor’s Trust that was also established contemporaneously under the Plan. As of December 31, 2016, the Trust was obligated to fund an additional $10 million. The Trust paid $5 million of the liability to the Creditor’s Trust in January 2017. The remaining balance is due in full in January 2018.

Premium Liability

As of September 30, 2017 and December 31, 2016, the Trust holds $31.1 million and $25.8 million, respectively, in escrow for future payment of premium obligations. To the extent advanced premiums received from the CFH are not used for premium payments, they are refunded to the respective CFH.

Pre-Effective Maturity Liabilities

On December 9, 2016, the Trust received funds related to maturities that occurred prior to the formation of the Trust. These funds are recognized as a liability on the accompanying balance sheet as pre-effective maturity liabilities owed to the fractional interest holders. Additionally, the Trust has recorded a receivable for maturities that occurred prior to December 9, 2016, where proceeds were not received as of that date. This receivable is $0 and $9.0 million as of September 30, 2017 and December 31, 2016, respectively and is included in pre-effective maturity liabilities on the accompanying balance sheet.

Recently Issued Accounting Pronouncements

Index

date of the new revenue recognition standard by one year. As a result, the provisions of this ASU are now effective for interim and annual periods beginning after December 15, 2017. The Trust does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows.

Item 4.

Controls and Procedures.

Internal Control Over Financial Reporting

In preparing our financial statements for the year ended December 31, 2016, we identified a material weakness in our internal control over financial reporting, as defined by the SEC guidelines for public companies. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for the oversight of the company’s financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

The material weakness identified relates to the Trust having not yet established processes and controls sufficient to ensure the accuracy of data and information regarding its policies, insured parties and position holder interests on an ongoing basis. In addition, such controls are not fully implemented at the servicer and Subservicer, and relevant controls to monitor the performance of those organizations are not yet in place. In response to this assessment, we implemented and are implementing entity level controls to provide oversight on financial reporting and cash management provided by the Servicing Company. In addition, the Servicing Company has begun to implement new accounting and operating systems that incorporate appropriate accounting controls over their assigned functions. We believe that the continued implementation of these measures will address and remedy this material weakness in our internal control over financial reporting.

Index

PART II—OTHER INFORMATION

Item 6.

Exhibits.

	Exhibit No.		Description
	31		Rule 13a-14(a) Certification

	32		Section 1350 Certification

	101.INS		XBRL Instance Document.
	101.SCH		XBRL Taxonomy Extension Schema Document.
	101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.
	101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.
	101.LAB		XBRL Taxonomy Extension Label Linkbase Document.
	101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.

Index

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

Dated: November 21, 2017

	LIFE PARTNERS POSITION HOLDER TRUST

	By:	/s/ Eduardo S. Espinosa
		Eduardo S. Espinosa, Trustee

	LIFE PARTNERS IRA HOLDER PARTNERSHIP LLC

	By:	/s/ Eduardo S. Espinosa
		Eduardo S. Espinosa, Manager

EX-31 2 ex31.htm EXHIBIT 31

EXHIBIT 31

CERTIFICATION

I, Eduardo S. Espinosa, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Life Partners Position Holder Trust and Life Partners IRA Holder Partnership, LLC;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 21, 2017

	/s/ Eduardo S. Espinosa
	Eduardo S. Espinosa
	Trustee, Life Partners Position Holder Trust
	Manager, Life Partners IRA Holder Partnership, LLC

EX-32 3 ex32.htm EXHIBIT 32

EXHIBIT 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Reports of Life Partners Position Holder Trust and Life Partners IRA Holder Partnership, LLC on Form 10-Q for the period ended September 30, 2017 as filed with the Securities and Exchange Commission (“Report”), I, Eduardo S. Espinosa, Trustee of Life Partners Position Holder Trust and Manager of Life Partners IRA Holder Partnership, LLC certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Life Partners Position Holder Trust and Life Partners IRA Holder Partnership, LLC.

A signed original of this written statement required by Section 906 has been provided to Life Partners Position Holder Trust and Life Partners IRA Holder Partnership, LLC and will be retained by each and furnished to the Securities and Exchange Commission or its Staff upon request.

Date: November 21, 2017

	/s/ Eduardo S. Espinosa
	Eduardo S. Espinosa
	Trustee, Life Partners Position Holder Trust
	Manager, Life Partners IRA Holder Partnership, LLC

The foregoing certification is being furnished solely pursuant to 18 U. S. C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

EX-101.INS 4 lpi-20170930.xml XBRL INSTANCE DOCUMENT 0001692144 2017-01-01 2017-09-30 0001692144 2017-09-30 0001692144 2016-12-31 0001692144 2017-07-01 2017-09-30 0001692144 2017-06-30 0001692144 2016-12-09 0001692144 2017-01-01 2017-01-31 0001692144 2016-12-01 2016-12-31 0001692144 2016-01-01 2016-12-31 0001692144 lpi:ViaticalSettlementContractMember 2016-12-31 0001692144 lpi:LifeSettlementContractsMember 2016-12-31 0001692144 lpi:LifeSettlementContractsMember 2017-09-30 0001692144 lpi:ViaticalSettlementContractMember 2017-09-30 0001692144 lpi:SinkingFundNotesPayableMember 2017-09-30 0001692144 lpi:TermLoanMember us-gaap:NotesPayableOtherPayablesMember 2016-12-09 0001692144 us-gaap:LineOfCreditMember 2016-12-09 0001692144 lpi:TermLoanMember us-gaap:NotesPayableOtherPayablesMember 2017-01-01 2017-09-30 0001692144 lpi:SinkingFundNotesPayableMember 2017-01-01 2017-09-30 0001692144 lpi:TermLoanMember us-gaap:NotesPayableOtherPayablesMember 2016-12-31 0001692144 us-gaap:NotesPayableOtherPayablesMember lpi:NotesPayableForChapter11TrusteeFeesMember 2017-09-30 0001692144 us-gaap:NotesPayableOtherPayablesMember lpi:NotesPayableForChapter11TrusteeFeesMember 2016-12-31 0001692144 lpi:TermLoanMember us-gaap:NotesPayableOtherPayablesMember 2017-09-30 0001692144 lpi:SinkingFundNotesPayableMember 2016-12-31 0001692144 us-gaap:LineOfCreditMember 2017-01-01 2017-09-30 0001692144 us-gaap:LineOfCreditMember 2016-12-31 0001692144 us-gaap:LineOfCreditMember 2017-09-30 0001692144 lpi:NotesPayableForChapter11TrusteeFeesMember us-gaap:NotesPayableOtherPayablesMember 2017-03-28 2017-03-28 0001692144 lpi:NotesPayableForChapter11TrusteeFeesMember us-gaap:NotesPayableOtherPayablesMember 2017-01-01 2017-09-30 0001692144 lpi:NotesPayableForChapter11TrusteeFeesMember us-gaap:NotesPayableOtherPayablesMember 2017-03-28 0001692144 lpi:NotesPayableForChapter11TrusteeFeesMember us-gaap:NotesPayableOtherPayablesMember 2016-01-01 2016-12-31 0001692144 us-gaap:NotesPayableOtherPayablesMember 2017-09-30 0001692144 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2016-12-31 0001692144 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001692144 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001692144 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001692144 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2017-09-30 0001692144 us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001692144 us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001692144 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2016-12-31 0001692144 lpi:ValuationTechniqueDiscountedCashFlowMember lpi:LifeSettlementContractsMember us-gaap:FairValueInputsLevel3Member 2016-12-31 0001692144 lpi:ValuationTechniqueDiscountedCashFlowMember lpi:LifeSettlementContractsMember us-gaap:FairValueInputsLevel3Member 2017-09-30 0001692144 us-gaap:FairValueInputsLevel3Member lpi:ValuationTechniqueDiscountedCashFlowMember lpi:LifeSettlementContractsMember 2016-01-01 2016-12-31 0001692144 us-gaap:FairValueInputsLevel3Member lpi:LifeSettlementContractsMember lpi:ValuationTechniqueDiscountedCashFlowMember 2017-01-01 2017-09-30 0001692144 lpi:LifeSettlementContractsMember us-gaap:FairValueInputsLevel3Member 2016-01-01 2016-12-31 0001692144 lpi:LifeSettlementContractsMember us-gaap:FairValueInputsLevel3Member 2017-01-01 2017-09-30 0001692144 lpi:ValuationTechniqueDiscountedCashFlowMember lpi:LifeSettlementContractsMember us-gaap:MaximumMember us-gaap:FairValueInputsLevel3Member 2017-01-01 2017-09-30 0001692144 lpi:ValuationTechniqueDiscountedCashFlowMember lpi:LifeSettlementContractsMember us-gaap:MinimumMember us-gaap:FairValueInputsLevel3Member 2016-01-01 2016-12-31 0001692144 lpi:ValuationTechniqueDiscountedCashFlowMember us-gaap:MaximumMember lpi:LifeSettlementContractsMember us-gaap:FairValueInputsLevel3Member 2016-01-01 2016-12-31 0001692144 lpi:ValuationTechniqueDiscountedCashFlowMember us-gaap:MinimumMember lpi:LifeSettlementContractsMember us-gaap:FairValueInputsLevel3Member 2017-01-01 2017-09-30 0001692144 us-gaap:CreditConcentrationRiskMember lpi:FairValueOfLifeInsurancePoliciesMember us-gaap:AMBestAPlusRatingMember lpi:TransamericaFinancialLifeInsuranceMember 2017-01-01 2017-09-30 0001692144 lpi:TheLincolnNationalLifeInsuranceMember us-gaap:CreditConcentrationRiskMember lpi:FairValueOfLifeInsurancePoliciesMember us-gaap:AMBestAPlusRatingMember 2017-01-01 2017-09-30 0001692144 lpi:JohnHancockLifeInsuranceUSAMember us-gaap:CreditConcentrationRiskMember lpi:FairValueOfLifeInsurancePoliciesMember us-gaap:AMBestAPlusRatingMember 2017-01-01 2017-09-30 0001692144 us-gaap:AMBestAPlusRatingMember lpi:FaceValueOfLifeInsurancePoliciesMember us-gaap:CreditConcentrationRiskMember lpi:TheLincolnNationalLifeInsuranceMember 2017-01-01 2017-09-30 0001692144 lpi:JohnHancockLifeInsuranceUSAMember us-gaap:AMBestAPlusRatingMember lpi:FaceValueOfLifeInsurancePoliciesMember us-gaap:CreditConcentrationRiskMember 2017-01-01 2017-09-30 0001692144 us-gaap:AMBestAPlusRatingMember lpi:FaceValueOfLifeInsurancePoliciesMember us-gaap:CreditConcentrationRiskMember lpi:TransamericaFinancialLifeInsuranceMember 2017-01-01 2017-09-30 0001692144 lpi:LifeSettlementContractsMember 2017-06-30 0001692144 lpi:LifeSettlementContractsMember 2016-12-31 0001692144 lpi:LifeSettlementContractsMember 2017-07-01 2017-09-30 0001692144 lpi:LifeSettlementContractsMember 2017-01-01 2017-09-30 0001692144 lpi:LifeSettlementContractsMember 2017-09-30 xbrli:shares iso4217:USD lpi:Shareholder lpi:Policy xbrli:pure lpi:Component lpi:Payment false --12-31 2017-09-30 Yes No No Smaller Reporting Company Life Partners Position Holder Trust 0001692144 0 2017 Q3 10-Q

2920403

200072

2900000

517469

1394557

393516178

382124126

203749554

240194687

218062519

1154518519

1012364792

8070105

23927247

103450137

90091951

-13358186

0.111

0.141

0.114

0.113

0.075

0.091

4038310

12402779

2800000

2018-12-09

2031-12-09

0.11

0.03

36500000

55000000

200000

1012355948

26200000

7700000

26170479

48847913

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Quantitative Information about Level 3 Fair Value Measurements</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Fair Value at</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">9/30/2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Face value at</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">9/30/2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Valuation</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Technique(s)</div></td><td valign="bottom" style="width: 2%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Unobservable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Inputs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Range</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">(Weighted Average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Life insurance policies</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,284,228,944</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Discounted cash flow</div></td><td valign="bottom" style="width: 2%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Discount rate</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25.2%-31.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 2%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;">      </td><td valign="bottom" style="width: 2%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Life expectancy evaluation</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right; text-indent: 2pt;">3.6 years</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Fair Value at</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">12/31/16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Face value at</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">12/31/16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Valuation</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Technique(s)</div></td><td valign="bottom" style="width: 2%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Unobservable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Inputs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Range</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">(Weighted Average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Life insurance policies</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,289,998,014</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Discounted cash flow</div></td><td valign="bottom" style="width: 2%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Discount rate</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24.7%-31.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table><div><br />  </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; vertical-align: bottom;"> </td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Fair Value at</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">12/31/16</div></td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Face value at</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">12/31/16</div></td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Valuation</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Technique(s)</div></td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Unobservable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Inputs</div></td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Range</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">(Weighted Average)</div></td></tr><tr><td style="width: 25%; vertical-align: bottom;"> </td><td style="width: 15%; vertical-align: bottom;">  </td><td style="width: 15%; vertical-align: bottom;">  </td><td style="width: 15%; vertical-align: bottom;"> </td><td style="width: 15%; vertical-align: bottom;"> </td><td style="width: 15%; vertical-align: bottom;"> </td></tr><tr><td style="width: 25%; vertical-align: bottom; background-color: #cceeff;"> </td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;">  </td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;">  </td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;"> </td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Life expectancy evaluation</div></td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right; margin-left: 2.2pt; margin-right: 2.2pt;">4.0 years</div></td></tr></table></div>

Discount rate

Life expectancy evaluation

0.317

0.247

0.317

0.252

50870826

19344711

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><u>Note 6 - Fair Value Measurements</u></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The Trust carries its life insurance policies at fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt;">Fair value measurements are classified based on the following fair value hierarchy:</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt;">Level 1 - Valuation is based on unadjusted quoted prices in active markets for identical assets and liabilities that are accessible at the reporting date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt;">Level 2 - Valuation is determined from pricing inputs that are other than quoted prices in active markets that are either directly or indirectly observable as of the reporting date. Observable inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and interest rates and yield curves that are observable at commonly quoted intervals.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt;">Level 3 - Valuation is based on inputs that are both significant to the fair value measurement and unobservable. Level 3 inputs include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value generally require significant management judgment or estimation.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The balances of the Trust's assets measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016, are as follows:</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of September 30, 2017:</div><div> </div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Total Fair </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Assets:</div></td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Investment in life insurance policies</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of December 31, 2016:</div><div> </div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Total Fair </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Assets:</div></td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Investment in life insurance policies</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Quantitative Information about Level 3 Fair Value Measurements</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Fair Value at</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">9/30/2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Face value at</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">9/30/2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Valuation</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Technique(s)</div></td><td valign="bottom" style="width: 2%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Unobservable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Inputs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Range</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">(Weighted Average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Life insurance policies</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,284,228,944</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Discounted cash flow</div></td><td valign="bottom" style="width: 2%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Discount rate</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25.2%-31.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 2%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;">      </td><td valign="bottom" style="width: 2%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Life expectancy evaluation</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right; text-indent: 2pt;">3.6 years</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Fair Value at</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">12/31/16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Face value at</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">12/31/16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Valuation</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Technique(s)</div></td><td valign="bottom" style="width: 2%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Unobservable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Inputs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Range</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">(Weighted Average)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 38%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Life insurance policies</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,289,998,014</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Discounted cash flow</div></td><td valign="bottom" style="width: 2%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Discount rate</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24.7%-31.7</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td></tr></table><div><br />  </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%; border-collapse: collapse;"><tr><td style="width: 25%; vertical-align: bottom;"> </td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Fair Value at</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">12/31/16</div></td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Face value at</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">12/31/16</div></td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Valuation</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Technique(s)</div></td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Unobservable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Inputs</div></td><td style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Range</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">(Weighted Average)</div></td></tr><tr><td style="width: 25%; vertical-align: bottom;"> </td><td style="width: 15%; vertical-align: bottom;">  </td><td style="width: 15%; vertical-align: bottom;">  </td><td style="width: 15%; vertical-align: bottom;"> </td><td style="width: 15%; vertical-align: bottom;"> </td><td style="width: 15%; vertical-align: bottom;"> </td></tr><tr><td style="width: 25%; vertical-align: bottom; background-color: #cceeff;"> </td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;">  </td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;">  </td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;"> </td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Life expectancy evaluation</div></td><td style="width: 15%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right; margin-left: 2.2pt; margin-right: 2.2pt;">4.0 years</div></td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Following is a description of the methodologies used to estimate the assets’ fair value measured on a recurring basis and within the above fair value hierarchy.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The Portfolio was valued using a probabilistic approach, which is actuarially based. This approach fits the Portfolio’s cash flows (premium payments and death benefits) to a monthly mortality scale as generated by each insured’s specific life expectancy. This mortality scale is actuarially rolled forward from the life expectancy underwriting date to the valuation date. This mathematical approach is substantially the same as actuaries customarily use in the pricing of life insurance and annuities. The Trust discounted the monthly cash flows with interest and survivorship back to the valuation date of as of September 30, 2017 and December 31, 2016, to arrive at the Portfolio’s estimated value.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The valuations presented here are net of a 2.65% servicing fee payable under the Plan. The Trust utilized each Policy’s “optimized” premium. The Trust relied on life expectancy values provided by its servicing company that were in turn provided to it from qualified industry experts. If a particular Policy did not have a life expectancy, the Trust used the Society of Actuaries’ 2015 Valuation Basic Tables, smoker distinct mortality tables developed by the U.S. Society of Actuaries (the “2015 VBT”) to obtain the average probability of death for similarly categorized persons and applied mortality multipliers by type/gender, to arrive at an estimated life expectancy for the insured. The mortality multipliers used are: 100% for the life settlement males, 100% for the life settlement females and 350% for the viaticals regardless of gender. The 2015 VBT are created based on the expected rates of death among different groups categorized by factors such as age and gender.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">If the insured dies earlier than expected, the return will be higher than if the insured dies when expected or later than expected. The Trust’s estimates allow for the possibility that if the insured dies earlier than expected, the premiums needed to keep the policy in force will not have to be paid. Conversely, the calculation also considers the possibility that if the insured lives longer than expected, more premium payments will be necessary.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Life expectancy estimates are a significant input in the fair value determination. Future changes in the life expectancy estimates could have a material effect on the Portfolio’s fair value, which could have a material effect on its financial condition and results of operations. Life expectancy estimates for insureds over the age of 90 years are less reliable than estimates for younger persons, due to the relative lack of statistical information as to the health and mortality expectations for those over the age of 90 years. Accordingly, there is a correspondingly lower statistical basis for relying on life expectancy estimates based on medical underwriting for insureds in that age group. In addition, the average probability of death calculated in the 2015 VBT for those 90 years or older has less statistical reliability than the average probability of death calculations for younger persons. Nevertheless, the majority of industry participants continue to rely on medical underwriting and the 2015 VBT for all age ranges, including 90 and over. As the average age of the insureds for the life settlements in the Portfolio is 89 years, the Trust will continue to evaluate its ongoing reliance on the 2015 VBT and life expectancies based on medical underwriting and make adjustments to its underlying assumptions as actuarial knowledge regarding this population advances.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Life expectancy sensitivity analysis</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The  table below reflects the effect on the PHT Portfolio’s fair value if the actual life expectancy experienced is 5% less or 5% more than is currently estimated. If the life expectancy estimate increases by 5% or decreases by 5%, the change in estimated fair value of the life insurance policies as of September 30, 2017 and December 31, 2016 would be as follows: <div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td nowrap="nowrap" valign="bottom" style="width: 57%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of September 30, 2017</div>Life Expectancy Months Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Average life expectancy</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Change in Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 57%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);">- 5%</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"></td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">301,220,686</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">15,064,966</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td></tr><tr><td nowrap="nowrap" valign="bottom" style="width: 57%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">No change</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">3.6 years</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td></tr><tr><td valign="bottom" style="width: 57%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);">+ 5%</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';"> </div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">271,624,213</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,531,507</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td nowrap="nowrap" valign="bottom" style="width: 57%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of December 31, 2016</div>Life Expectancy Months Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Average life expectancy</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Change in Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 57%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);">- 5%</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"></td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">277,276,497</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">13,697,457</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td></tr><tr><td nowrap="nowrap" valign="bottom" style="width: 57%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">No change</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">4.0 years</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td></tr><tr><td valign="bottom" style="width: 57%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);">+ 5%</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';"> </div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">249,069,410</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,509,630</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Discount rate</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The discount rate is another significant input in the fair value determination. The Trust’s estimate incorporates market factors, the size of the portfolio, and various policy specific quantitative and qualitative factors including known information about the underlying insurance policy, its economics, the insured and the insurer.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The effect of changes in the weighted average discount rate on the death benefit and premiums used to estimate the PHT Portfolio’s fair value has been analyzed. If the weighted average discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of September 30, 2017 and December 31, 2016 would be as follows:</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td nowrap="nowrap" valign="bottom" style="width: 69%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of September 30, 2017</div>Rate Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 5pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 5pt;">Change in Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 69%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">+2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">273,359,032</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">(12,796,688</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td nowrap="nowrap" valign="bottom" style="width: 69%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">No change</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td></tr><tr><td valign="bottom" style="width: 69%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">-2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><font style="background-color: rgb(255,255,255);"></font></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">300,310,106</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,154,386</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td nowrap="nowrap" valign="bottom" style="width: 69%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of December 31, 2016</div>Rate Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 5pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 5pt;">Change in Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 69%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">+2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">250,218,915</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">(13,360,125</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td nowrap="nowrap" valign="bottom" style="width: 69%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">No change</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td></tr><tr><td valign="bottom" style="width: 69%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">-2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><font style="background-color: rgb(255,255,255);"></font></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">278,442,322</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,863,282</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td></tr></table></div><div> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Future changes in the discount rates used by the Trust to value life insurance policies could have a material effect on the Trust's yield on life settlement transactions, which could have a material adverse effect on the Trust’s financial condition and results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The Trust re-evaluates its discount rates at the end of every reporting period in order to estimate the discount rates that could reasonably be used by market participants in a transaction involving the Trust's life insurance policies. In doing so, the Trust engages third party consultants to corroborate its assessment, engages in discussions with other market participants and extrapolates the discount rate underlying actual sales of insurance policies. <div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"> </div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Credit Exposure to Insurance Companies</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit or 10% of total fair value of the Trust's life insurance policies as of September 30, 2017:</div><div> </div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Carrier</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Percentage of</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Face Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Percentage of</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Carrier Rating</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">The Lincoln National Life Insurance</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11.3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14.1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">A</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">+</div></td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">John Hancock Life Insurance (USA)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7.5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11.4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">A</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">+</div></td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Transamerica Financial Life Insurance</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9.1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">11.1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">A</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">+</div></td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Changes in Fair Value</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The following table provides a roll-forward in the changes in fair value for the three and nine months ended September 30, 2017, for the Trust’s life insurance policies:</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three months ended</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3.3pt;">Nine months ended</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Beginning balance</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">273,147,684</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Change in fair value</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">26,170,479</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">48,847,913</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Matured policies, net of fees</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(19,344,711</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(50,870,826</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Premiums paid</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,182,269</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24,599,593</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Ending balance</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: bold; text-align: left; background-color: #ffffff;">$</td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Changes in fair value included in earnings for the period relating to assets held at September 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,480,259</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,973,378</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr></table></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Changes in Fair Value</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The following table provides a roll-forward in the changes in fair value for the three and nine months ended September 30, 2017, for the Trust’s life insurance policies:</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three months ended</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3.3pt;">Nine months ended</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Beginning balance</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">273,147,684</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Change in fair value</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">26,170,479</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">48,847,913</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Matured policies, net of fees</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(19,344,711</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(50,870,826</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Premiums paid</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,182,269</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24,599,593</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Ending balance</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: bold; text-align: left; background-color: #ffffff;">$</td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Changes in fair value included in earnings for the period relating to assets held at September 30, 2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,480,259</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,973,378</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr></table></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The balances of the Trust's assets measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016, are as follows:</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of September 30, 2017:</div><div> </div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Total Fair </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Assets:</div></td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Investment in life insurance policies</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of December 31, 2016:</div><div> </div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Level 3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Total Fair </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Assets:</div></td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Investment in life insurance policies</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table></div>

273147684

263579040

286155720

375

10855

933519

-778428

2720331

-97525

870671

-661878

5350329

7386420

12145715

1805161

5422804

3403128

633272

3467789

178374572

153321491

59109822

69880054

29193315

42876670

108

942298899

807373873

38672708

42137638

2879

2999

26906072

56207688

26251734

35859153

81805300

53027573

35577890

28775972

95930412

87802823

22344600

43884176

181159206

112725236

92622111

111538793

1100000000

1289998014

1284228944

191200000

1100000000

180400000

1289998014

1284228944

1289998014

1284228944

263579040

286155720

2500000

283700000

261600000

2000000

286155720

263579040

286155720

48847912

26170478

3252

3177

2598

654

620

2577

2018-12-09

25000000

2432886

55000000

2600000

55000000

36500000

36493298

94243298

916666

2432886

916667

2432886

916667

2432886

55000000

2432886

36493298

24328868

22382608

-35740794

22132168

36445133

94067102

94010671

48847912

26170478

721883

179369

24599593

661878

5000000

67342

164867

46982201

1420133

2779448

82021846

79522890

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Future scheduled principal payments on the above notes payable and required sinking fund contributions are as follows as of September 30, 2017:</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 2px;">   </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 7pt;">Sinking Fund</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 7pt;">Notes Payable</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,432,886</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2018</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,432,886</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">55,000,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2019</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,432,886</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">916,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2020</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,432,886</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">916,667</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2021</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,432,886</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">916,666</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Thereafter</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24,328,868</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">36,493,298</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 70%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">36,493,298</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">94,243,298</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td></tr></table></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div>The following tables summarizes the Trust's life insurance policies grouped by remaining life expectancy as of September 30 ,2017 and December 31, 2016:</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of September 30, 2017:</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Remaining Life Expectancy (Years)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Number of</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Life</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Insurance</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Policies</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Face Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">0-1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">56,207,688</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">43,884,176</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">1-2</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">44</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69,880,054</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42,137,638</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">2-3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">64</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">81,805,300</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35,859,153</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">3-4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">57</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">87,802,823</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">28,775,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">4-5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">108</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">181,159,206</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42,876,670</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Thereafter</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,879</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">807,373,873</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">92,622,111</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 62%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">3,177</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">1,284,228,944</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of December 31, 2016:</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Remaining Life Expectancy (Years)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Number of</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Life</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Insurance</div><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Policies</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Face Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Fair Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">0-1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">19</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">26,906,072</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22,344,600</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">1-2</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">29</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">59,109,822</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">38,672,708</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">2-3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">60</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">53,027,573</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">26,251,734</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">3-4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">59</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">95,930,412</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35,577,890</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">4-5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">86</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">112,725,236</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">29,193,315</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Thereafter</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,999</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">942,298,899</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">111,538,793</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 62%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">3,252</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">1,289,998,014</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table></div>

4102099

3323671

5500000

25776263 31126592 5741922 334797 10000000 5000000 5055450 6881784 38026076 15154369 44400000 27500000 25.8 29900000 0 -1826334 -5407125 -5000000 -22871707 0.95 12243 10386 0.05 0.95 2 1 1 0.2 5000000 2000000 0.04 P10Y 0 9000000 2800000 3 0.03 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Estimated premiums to be paid by the Trust for its portfolio during each of the five succeeding fiscal years and thereafter as of September 30, 2017, are as follows:</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"> </div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 88%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2017</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">9,852,086</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2018</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">43,706,522</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2019</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">50,208,934</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2020</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">51,169,045</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">2021</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">46,980,546</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Thereafter</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">207,370,714</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 16.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">409,287,847</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table></div> P3Y7M6D P4Y 51169045 9852086 46980546 207370714 409287847 50208934 43706522 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Description of Securities</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Units represent beneficial interests in the Trust, and all holders of Units are entitled to receive cash distributions from the Trust in accordance with their respective Pro Rata shares. A Trust beneficiary’s respective “Pro Rata Share” means the ratio, expressed as a percentage, of (i) the number of Units which such Trust beneficiary is the registered owner, to (ii) the total number of Units outstanding as of the measurement date, subject to modification for purposes of distributing any recovered assets.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Initial units of Position Holder Trust Interest were issued on the basis of one (1) Unit for each $1 of death benefit payable (rounded to the nearest dollar) associated with the ownership of Fractional Positions. Subsequent issuances of Units will be issued to continuing fractional interest holders if they default on their premium payment obligations. Such Units will be issued in exchange for the defaulting position, in accordance with the basis and discounts delineated in the Plan, as recently modified by the Bankruptcy Court. Each Unit holder has the same rights with respect to each Unit as every other Unit holder.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Unit holders do not have any voting rights under the Position Holder Trust Agreement with respect to the appointment of any successor to the Trustee, filling any vacancy on the Governing Trust Board or any action to be taken by the Position Holder Trust, including without limitation whether the duration of the Trust should be extended after the end of the initial 10-year term. Unit holders have no liability for the debts and other obligations of the Position Holder Trust and bear no expenses in connection with the organization and administration of the Trust. The Trust is a pass-through tax entity and its Unit holders may be allocated taxable income without a matching cash distribution, leading to an unfunded tax obligation. The Trust has the right, but not the obligation, to offset against any distributions allocated to any Unit holder in an amount equal to all unpaid amounts owed by the holder, including all unpaid amounts owed for catch-up payments, pre-petition default amounts and post-effective date payment defaults.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Under the Plan, the Trustee will distribute at least annually to the Unit holders all of the distributable cash (as defined in the Position Holder Trust Agreement) generated during each calendar year, subject to any reserve established by the Trustee reasonably necessary to maintain the value of the Registrant’s assets or to meet claims and contingent liabilities. All distributions by the Trust will be made in accordance with such holder’s Pro Rata share of the outstanding Units.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Risks and Uncertainties</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The Trust encounters economic, legal, and longevity risk. The two main components of economic risk potentially impacting the Trust are market risk and concentration of credit risk. The Trust’s market risks include interest rate risk and the risk of declines in valuation of the Trust’s life insurance policies, including declines caused by the selection of increased discount rates associated with the Trust’s fair value model. It is reasonably possible that future changes to estimates involved in valuing life insurance policies could change and result in material effects to the future financial statements. Concentration of credit risk is the risk that an insurance carrier who has issued life insurance policies held by the Trust, does not remit the amount due under those policies due to the deteriorating financial condition of the carrier or otherwise. Another credit risk potentially impacting the Trust is the risk continuing fractional holders may default on their future premium obligations, increasing the Trust’s premium liability.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">There exists a legal risk courts would allow insurance carriers to retain premiums paid by the Trust in respect of insurance policies that are successfully rescinded or contested. In addition, our title or right to benefit from an insurance policy may be challenged by the insurer or the insured’s family.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Longevity risk refers to the reasonable possibility that actual mortalities of insureds in the Trust’s portfolio extend over longer periods than are anticipated, resulting in the Trust paying more for premiums.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The Trust maintains the majority of its cash in several accounts with a commercial bank. Balances on deposit are insured by the Federal Deposit Insurance Corporation (“FDIC”). However, from time to time the Trust's balances may exceed the FDIC insurable amount at its banks.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Fair Value of Life Insurance Policies</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The Trust follows ASC 820,<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> Fair Value Measurements and Disclosures</font>, in estimating the fair value of its life insurance policies, which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. <div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">As a basis for considering such assumptions, the guidance establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Trust’s investments in life insurance policies are considered to be Level 3 as there is currently no active market where the Trust is able to observe quoted prices for identical assets and the Trust’s valuation model incorporates significant inputs that are not observable.</div></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The Trust’s valuation of life insurance policies is a critical estimate within the financial statements. The Trust currently uses a probabilistic method of valuing life insurance policies, which the Trust believes to be the preferred valuation method in its industry. The Trust calculates the assets’ fair value using a present value technique to estimate the fair value of the projected future cash flows. The most significant assumptions in estimating the fair value are the Trust’s estimate of the insureds’ life expectancy and the discount rate. See Note 6, “Fair Value Measurements.”</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Accounts Payable and Accrued Expenses</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Accounts payable and accrued expenses primarily include professional services, legal fees and expected litigation settlements, some of which are obligations assumed by the Trust that were incurred prior to the effective date of the Trust. The Trust also accrues liabilities for state taxes payable and other miscellaneous accruals. The Trust accrues liabilities when costs are incurred and such costs can be reasonably estimated. Accrued expenses related to the Debtors’ bankruptcy are included in assumed liabilities on the accompanying balance sheet.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Continuing Fractional Interests</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The continuing fractional interest of a fractional interest holder who made a continuing holder election will represent 95% of the beneficial ownership associated with the Fractional Interest with respect to which the Election was made, with the other 5% comprising the Continuing Position Holder Contribution made to the Position Holder Trust on the Effective Date. The continuing fractional interest holder ("CFH") is obligated to pay 95% of the premium payments and policy expenses allocable to the fractional interest. Upon maturity of a Policy, the CFH with positions in the Policy will be entitled to receive the Policy proceeds allocable to each such continuing fractional interest held. The Policy proceeds paid to a CFH will be reduced by (1) the servicing fee payable with respect to each such continuing fractional interest, and (2) any premium amount paid by the Trust prior to the date of death with respect to the continuing fractional interest that is not refunded as a result of the maturity.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Upon the occurrence of a payment default with respect to a continuing fractional interest, the CFH will be deemed to have contributed the position to the Trust at a discount of 20%, effective as of the payment default date.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Pre-Effective Maturity Liabilities</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">On December 9, 2016, the Trust received funds related to maturities that occurred prior to the formation of the Trust. These funds are recognized as a liability on the accompanying balance sheet as pre-effective maturity liabilities owed to the fractional interest holders. Additionally, the Trust has recorded a receivable for maturities that occurred prior to December 9, 2016 where proceeds were not received as of that date. This receivable was $0 and $9.0 million as of September 30, 2017 and December 31, 2016 respectively and is included in pre-effective maturity liabilities on the accompanying balance sheet.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Premium Liability</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">As of September 30, 2017 and December 31, 2016, the Trust holds $31.1 million and $25.8 million, respectively, in escrow for future payment of premium obligations. To the extent advanced premiums received from continuing fractional holders are not used for premium payments, they are refunded to the respective continuing fractional holder.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Maturities Receivable</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Maturities receivable consist of the Trust’s portion of life insurance policy maturities that occurred but payment was not yet received.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Creditors’ Trust Funding Liability</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">Pursuant to the Plan, in December 2016 and January 2017, the Trust contributed $2 million and $5 million respectively, to the Creditor’s Trust that was also established contemporaneously under the Plan. As of September 30, 2017, the Trust is obligated to fund an additional $5 million in January 2018.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The  table below reflects the effect on the PHT Portfolio’s fair value if the actual life expectancy experienced is 5% less or 5% more than is currently estimated. If the life expectancy estimate increases by 5% or decreases by 5%, the change in estimated fair value of the life insurance policies as of September 30, 2017 and December 31, 2016 would be as follows: <div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td nowrap="nowrap" valign="bottom" style="width: 57%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of September 30, 2017</div>Life Expectancy Months Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Average life expectancy</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Change in Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 57%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);">- 5%</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"></td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">301,220,686</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">15,064,966</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td></tr><tr><td nowrap="nowrap" valign="bottom" style="width: 57%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">No change</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">3.6 years</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td></tr><tr><td valign="bottom" style="width: 57%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);">+ 5%</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';"> </div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">271,624,213</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,531,507</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td nowrap="nowrap" valign="bottom" style="width: 57%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of December 31, 2016</div>Life Expectancy Months Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">Average life expectancy</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 2pt;">Change in Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 57%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);">- 5%</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"></td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">277,276,497</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">13,697,457</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td></tr><tr><td nowrap="nowrap" valign="bottom" style="width: 57%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">No change</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center; margin-left: 2.2pt; margin-right: 2.2pt;">4.0 years</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td></tr><tr><td valign="bottom" style="width: 57%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);">+ 5%</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';"> </div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">249,069,410</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,509,630</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: 18pt;">The effect of changes in the weighted average discount rate on the death benefit and premiums used to estimate the PHT Portfolio’s fair value has been analyzed. If the weighted average discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of September 30, 2017 and December 31, 2016 would be as follows:</div><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td nowrap="nowrap" valign="bottom" style="width: 69%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of September 30, 2017</div>Rate Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 5pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 5pt;">Change in Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 69%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">+2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">273,359,032</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">(12,796,688</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td nowrap="nowrap" valign="bottom" style="width: 69%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">No change</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">286,155,720</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td></tr><tr><td valign="bottom" style="width: 69%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; margin-left: 9pt; text-indent: -9pt;">-2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><font style="background-color: rgb(255,255,255);"></font></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">300,310,106</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,154,386</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td></tr></table><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td nowrap="nowrap" valign="bottom" style="width: 69%; vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">As of December 31, 2016</div>Rate Adjustment</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 5pt;">Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: rgb(0,0,0) 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 5pt;">Change in Value</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 69%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">+2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">250,218,915</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">(13,360,125</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td nowrap="nowrap" valign="bottom" style="width: 69%; vertical-align: bottom; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">No change</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">263,579,040</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(255,255,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(255,255,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(255,255,255);"> </td></tr><tr><td valign="bottom" style="width: 69%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">-2%</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><font style="background-color: rgb(255,255,255);"></font></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">278,442,322</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: rgb(204,238,255);"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 12%; vertical-align: bottom; text-align: right; background-color: rgb(204,238,255);"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,863,282</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: rgb(204,238,255);"> </td></tr></table></div> P89Y 0.0265 1 P4Y P3Y7M6D P90Y 1 3.5 277276497 301220686 271624213 249069410 -14509630 -14531507 15064966 13697457 273359032 250218915 300310106 278442322 -13360125 -12796688 14863282 14154386 24599593 6182269 9480259 5973378

EX-101.SCH 5 lpi-20170930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - STATEMENT OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - STATEMENT OF CHANGES IN NET ASSETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - STATEMENT OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Operations and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Restricted Cash and Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Life Insurance Policies link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 070100 - Disclosure - Operations and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 080400 - Disclosure - Life Insurance Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 080500 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Operations and Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Restricted Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Life Insurance Policies (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 090502 - Disclosure - Notes Payable, Future Scheduled Principal Payments of Notes Payable and Sinking Fund Contributions (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Fair Value Measurements, Assets Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 090602 - Disclosure - Fair Value Measurements, Quantitative Information about Level 3 Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 090604 - Disclosure - Fair Value Measurements, Change in Estimated Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 090606 - Disclosure - Fair Value Measurements, Life Insurance Issuer Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 090608 - Disclosure - Fair Value Measurements, Changes in Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 lpi-20170930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 lpi-20170930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 lpi-20170930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity [Domain] Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Legal Entity [Axis] Document Type Carrier A+ Rating [Member] AM Best, A+ Rating [Member] Operations and Significant Accounting Policies [Abstract] Accounts payable Accounts Payable Income tax liabilities of Debtors assumed Accrued Income Taxes, Noncurrent Accrued expenses Accrued Liabilities Supplemental cash flow information: Additional Cash Flow Elements, Summations [Abstract] Adjustments to reconcile net increase in net assets to net cash used in operations: Assets [Abstract] Assets, Fair Value Disclosure [Abstract] Assets Assets [Abstract] Total assets Assets Net assets Net assets, beginning of period Net assets, end of period Net Assets Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Number of units outstanding (in shares) Capital Units, Outstanding Restricted Cash and Cash Equivalents Cash and Cash Equivalents Disclosure [Text Block] Cash Cash, beginning of period Cash, end of period Cash and Cash Equivalents, at Carrying Value Net (decrease) in cash Cash and Cash Equivalents, Period Increase (Decrease) Restricted Cash and Cash Equivalents [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and contingencies (Note 2) Commitments and Contingencies [Abstract] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Concentration Risk [Line Items] Concentration Risk [Line Items] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk [Table] Concentration Risk [Table] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Concentrations risk percentage Concentration Risk, Percentage Expenses Total expenses Costs and Expenses Credit Concentration Risk [Member] Credit Concentration Risk [Member] Credit Rating, AM Best [Domain] Credit Rating, AM Best [Axis] Credit Facility [Domain] Credit Facility [Axis] Debt Instrument [Axis] Notes Payable Debt Disclosure [Text Block] Notes Payable [Abstract] Long term debt, gross Debt instrument, maturity date Debt instrument, interest rate Debt Instrument, Interest Rate, Stated Percentage Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Debt instrument face amount Debt Instrument, Name [Domain] Note payable discount amount Debt Instrument, Unamortized Discount Number of units of beneficial interest issued to fractional interest holders (in shares) Pre-effective maturity escrow Change in fair value Fair Value Inputs, Assets, Quantitative Information [Line Items] Quantitative Information about Level 3 Fair Value Measurements Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block] Unobservable inputs Fair Value Measurements, Valuation Techniques Fair Value Inputs, Assets, Quantitative Information [Table] Discount rate Matured policies, net of fees Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements Fair Value, Hierarchy [Axis] Measurement Frequency [Axis] Asset Class [Axis] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Measurement Frequency [Domain] Fair Value Measurements [Abstract] Asset Class [Domain] Recurring [Member] Fair Value Hierarchy [Domain] Fair Value Measurements Changes in Fair Value for Trusts Life Insurance Policies Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Changes in Fair Value [Roll Forward] Assets Measured at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Level 1 [Member] Level 2 [Member] Level 3 [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Insurance Income Taxes [Abstract] Income Approach Valuation Technique [Member] STATEMENT OF OPERATIONS (UNAUDITED) [Abstract] Income Taxes Income Tax, Policy [Policy Text Block] Accrued expenses Assumed tax liability Increase (Decrease) in Income Taxes Payable Accounts payable Increase (Decrease) in Accounts Payable Change in assets and liabilities: Prepaids and other assets Increase (Decrease) in Prepaid Expense and Other Assets Maturities receivable Increase (Decrease) in Insurance Settlements Receivable Premiums receivable, net Increase (Decrease) in Premiums Receivable Premiums payable Increase (Decrease) in Unearned Premiums Maturities receivable Insurance Settlements Receivable Interest expense Cash paid for interest Life Insurance Policies [Abstract] Long-term Debt, Type [Domain] Long-term Debt, Type [Axis] Legal Fees Liabilities Liabilities [Abstract] Total liabilities Liabilities 1-2 Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Year Two 4-5 Life Settlement Contracts, Fair Value, Maturing in Year Five 4-5 Thereafter Life Settlement Contracts, Fair Value Method, Face Value, Maturing after Year Five Fair value [Abstract] 1-2 Life Settlement Contracts, Fair Value, Maturing in Year Two 2-3 Thereafter Life Settlement Contracts, Fair Value Method, Number of Contracts, Maturing after Year Five 3-4 0-1 Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Remainder of Fiscal Year 2-3 Life Settlement Contracts, Fair Value, Maturing in Year Three 0-1 Face value [Abstract] 2-3 Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Year Three 3-4 Life Settlement Contracts, Fair Value, Maturing in Year Four Number of life insurance policies [Abstract] 1-2 3-4 Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Year Four 0-1 Life Settlement Contracts, Fair Value, Maturing in Remainder of Fiscal Year 4-5 Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Year Five Thereafter Life Settlement Contracts, Fair Value, Maturing after Year Five Total Face value Life Settlement Contracts, Fair Value Method, Face Value Aggregate face value of life insurance policies No change, value Life insurance policies Total Fair value of life insurance policies Investments in Life Insurance Policies Life Settlement Contracts, Policy [Policy Text Block] Change in fair value of life insurance policies Change in fair value of life insurance policies Life Settlement Contracts, Fair Value Method, Unrealized Gain (Loss) Life Insurance Policies Number of life insurance policies Total Line of credit, maturity date Line of credit, outstanding amount Revolving Line of Credit [Member] Line of credit, maximum borrowing capacity 2017 Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year Long term debt, outstanding amount Long-term debt Future scheduled principal payments [Abstract] 2021 Long-term Debt, Maturities, Repayments of Principal in Year Five 2020 Long-term Debt, Maturities, Repayments of Principal in Year Four 2019 Long-term Debt, Maturities, Repayments of Principal in Year Three 2018 Long-term Debt, Maturities, Repayments of Principal in Year Two Thereafter EX-101.PRE 9 lpi-20170930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2017 shares
Document and Entity Information [Abstract]
Entity Registrant Name	Life Partners Position Holder Trust
Entity Central Index Key	0001692144
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	0
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017

XML 11 R2.htm IDEA: XBRL DOCUMENT

BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Assets
Cash	$ 8,070,105	$ 23,927,247
Maturity escrow held by third party	5,055,450	6,881,784
Maturities receivable	12,145,715	7,386,420
Premiums receivable, net	0	661,878
Prepaids and other assets	67,342	164,867
Restricted cash and cash equivalents	82,021,846	79,522,890
Life insurance policies	286,155,720	263,579,040
Total assets	393,516,178	382,124,126
Liabilities
Notes Payable	94,067,102	94,010,671
Assumed tax liability	3,323,671	4,102,099
Creditor trust funding	5,000,000	10,000,000
Premium liability	31,126,592	25,776,263
Pre-effective maturity liabilities	15,154,369	38,026,076
Accounts payable	2,920,403	200,072
Assumed liabilities	334,797	5,741,922
Accrued expenses	1,394,557	517,469
Commitments and contingencies (Note 2)
Total liabilities	153,321,491	178,374,572
Net assets	$ 240,194,687	$ 203,749,554

XML 12 R3.htm IDEA: XBRL DOCUMENT

STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended	9 Months Ended
STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)	Sep. 30, 2017	Sep. 30, 2017
Income
Change in fair value of life insurance policies	$ 26,170,478	$ 48,847,912
Total income	26,170,478	48,847,912
Expenses
Interest expense	1,805,161	5,422,804
Legal Fees	633,272	3,467,789
Professional Fees	1,420,133	2,779,448
Insurance	375	10,855
Other general and administrative	179,369	721,883
Total expenses	4,038,310	12,402,779
Net increase in net assets resulting from operations	$ 22,132,168	$ 36,445,133

XML 13 R4.htm IDEA: XBRL DOCUMENT

STATEMENT OF CHANGES IN NET ASSETS (UNAUDITED) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2017
STATEMENT OF CHANGES IN NET ASSETS (UNAUDITED) [Abstract]
Net assets, beginning of period	$ 218,062,519	$ 203,749,554
Net increase in net assets resulting from operations	22,132,168	36,445,133
Net assets, end of period	$ 240,194,687	$ 240,194,687

XML 14 R5.htm IDEA: XBRL DOCUMENT

STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)	Sep. 30, 2017
Cash flows from operating activities:
Net increase in net assets resulting from operations	$ 36,445,133
Adjustments to reconcile net increase in net assets to net cash used in operations:
Change in fair value of life insurance policies	(48,847,912)
Change in assets and liabilities:
Maturity escrow held by third party	1,826,334
Prepaids and other assets	97,525
Premiums receivable, net	661,878
Maturities receivable	(870,671)
Assumed tax liability	(778,428)
Pre-effective maturity liabilities	(22,871,707)
Creditor trust funding	(5,000,000)
Premiums payable	5,350,329
Accounts payable	2,720,331
Accrued expenses	933,519
Assumed liabilities	(5,407,125)
Net cash flows used in operating activities	(35,740,794)
Cash flows used in investing activities:
Contributed cash	0
Premiums paid on life insurance policies	(24,599,593)
Proceeds from maturity of life insurance policies	46,982,201
Proceeds from issuance of notes payable	0
Payments on maturity funds facility	0
Net cash flows used in investing activities	22,382,608
Net (decrease) in cash	(13,358,186)
Cash, beginning of period	103,450,137
Cash, end of period	90,091,951
Supplemental cash flow information:
Cash	8,070,105
Restricted cash and cash equivalents	82,021,846
Supplemental cash flow information:
Cash paid for interest	$ 3,403,128

XML 15 R6.htm IDEA: XBRL DOCUMENT

Operations and Significant Accounting Policies	9 Months Ended
Operations and Significant Accounting Policies	Sep. 30, 2017
Operations and Significant Accounting Policies [Abstract]
Operations and Significant Accounting Policies	Note 1 - Operations and Significant Accounting Policies Operations Life Partners Position Holder Trust (the “Trust”) was created on December 9, 2016, pursuant to the Revised Third Amended Joint Plan of Reorganization of Life Partners Holdings, Inc., et al. (collectively, the “Debtors”), dated as of October 27, 2016, which we call the “Plan,” that was confirmed by order of the United States Bankruptcy Court for the Northern District of Texas, Fort Worth Division on November 1, 2016. Life Partners Holdings, Inc. was the parent company of Life Partners, Inc., a Texas corporation, and its wholly-owned subsidiary LPI Financial Services, Inc., a Texas corporation (collectively, the “Debtors”). From 1991 until 2014, Life Partners, Inc. was a specialty financial services company engaged in the business of purchasing individual life insurance policies from third parties by raising money from the offer and sale to investors of “fractional interests” in such policies. LPI Financial Services, Inc. was organized to bill and collect certain fees charged to investors in connection with the business. Life Partners and LPI Financial Services also filed for protection under Chapter 11 of the Bankruptcy Code. In connection with its formation and the inception of its activities on December 9, 2016, the Trust issued a total of 1,012,355,948 units of beneficial interest (the “Units”) to the fractional interest holders having claims in the Debtors bankruptcy pursuant to the Plan. Each fractional interest holder received a Unit for each dollar of expected death benefit such holder contributed to the Trust. As of September 30, 2017 and December 31, 2016, there were 10,386 and 12,243 holders of the 1,154,518,519 and 1,012,364,792 Units outstanding, respectively. The Trust owns a portfolio of life insurance policies; a portion of the policies is encumbered by the economic interest of continuing fractional interest holders. The Trust’s portion of the portfolio consists of 3,177 and 3,252 life insurance policies, with fair values of $286.2 million and $263.6 million and an aggregate face value of approximately $1.3 billion and $1.3 billion at September 30, 2017 and December 31, 2016, respectively. The fair value of the interests in the life insurance policies owned by continuing fractional interest holders are not reflected in the financial statements of the Trust. Summary of Significant Accounting Policies Basis of Presentation The Trust’s primary purpose is the liquidation of the Trust’s assets and the distribution of proceeds to its beneficial interest holders. The Trust expects that fulfilling its purpose requires a significant amount of time, and that the Trust will have significant ongoing operations during that period due to the nature of its assets and its plan to maximize the proceeds to its beneficiaries by maintaining the majority of its life insurance policies until maturity. As a result, the Trust has concluded that its liquidation is not imminent, in accordance with the definitions under accounting principles generally accepted in the United States of America, and has not applied the liquidation basis of accounting in presenting its financial statements. The Trust will continue to evaluate its operations to determine when its liquidation becomes imminent and the liquidation basis of accounting is required. Investments in Life Insurance Policies The Trust accounts for its interests in life insurance policies at fair value in accordance with ASC 325-30, Investments in Insurance Contracts. The Trust initially recognized the life insurance policies transferred at its inception at their fair market value on December 9, 2016 and the Trust will estimate the fair value of its life insurance policies and recognize changes therein at each subsequent reporting period. Fair Value of Life Insurance Policies The Trust follows ASC 820, Fair Value Measurements and Disclosures, in estimating the fair value of its life insurance policies, which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Trust’s investments in life insurance policies are considered to be Level 3 as there is currently no active market where the Trust is able to observe quoted prices for identical assets and the Trust’s valuation model incorporates significant inputs that are not observable. The Trust’s valuation of life insurance policies is a critical estimate within the financial statements. The Trust currently uses a probabilistic method of valuing life insurance policies, which the Trust believes to be the preferred valuation method in its industry. The Trust calculates the assets’ fair value using a present value technique to estimate the fair value of the projected future cash flows. The most significant assumptions in estimating the fair value are the Trust’s estimate of the insureds’ life expectancy and the discount rate. See Note 6, “Fair Value Measurements.” Income Recognition The Trust’s investments in life insurance policies are its primary source of income. Gain or loss is recognized from ongoing changes in the portfolio’s estimated fair value, including any gains or losses at maturity. Gains or losses from maturities are recognized at receipt of a death notice or verified obituary for an insured party, and determined based on the difference between the death benefit and the estimated fair value of the policy at maturity. Premiums Receivable The Trust assumed the Debtors’ receivables related to life insurance policy premiums and service fees that were paid by the Debtors on behalf of fractional interest holders prior to the Trust’s effective date. After December 9, 2016, the policy premiums allocable to continuing fractional interest holders are those persons' obligations and not the Trust. If a continuing fractional interest holder defaults on future premium obligations, such position is deemed contributed to the Trust in exchange for the number of Units provided by the Plan, as recently modified by the Bankruptcy Court The Trust maintains an allowance for doubtful accounts for estimated losses resulting from the inability to collect premiums and service fees receivable. Such estimates are based on the position holder’s payment history and other indications of potential uncollectability. After all attempts to collect a receivable have failed, receivables are written off against the allowance. At September 30, 2017 and December 31, 2016, the allowance for doubtful accounts was $5.0 million, all of which was for receivables assumed from the Debtors on the effective date. Outstanding receivable balances may be recoverable pursuant to the Trustee’s set-off rights under the Plan. Maturities Receivable Maturities receivable consist of the Trust’s portion of life insurance policy maturities that occurred but payment was not yet received. Income Taxes No provision for state or Federal income taxes has been made as the liability for such taxes is attributable to the Unit holders rather than the Trust. The Trust is a grantor trust with taxable income or loss passing through to the Unit holders. In certain instances, however, the Trust may be required under applicable state laws to remit directly to state tax authorities amounts otherwise due to Unit holders. Such payments on behalf of the Unit holders are deemed distributions to them. The Financial Accounting Standards Board (the “FASB”) has provided guidance for how uncertain tax positions should be recognized, measured, disclosed, and presented in the financial statements. This requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Trust’s tax returns to determine whether the tax positions are more-likely-than-not of being sustained when challenged or when examined by the applicable taxing authority. The Trust has no material uncertain income tax positions as of September 30, 2017 or December 31, 2016. The Trust also assumed income tax liabilities of the Debtors at its inception which total approximately $2.9 million as of September 30, 2017 and December 31, 2016 related to taxes, penalties, and interest from the Debtors’ 2008, 2009 and 2010 income tax returns. These obligations bear interest at 4% annually and are due in full by January 2020. Accounts Payable and Accrued Expenses Accounts payable and accrued expenses primarily include professional services, legal fees and expected litigation settlements, some of which are obligations assumed by the Trust that were incurred prior to the effective date of the Trust. The Trust also accrues liabilities for state taxes payable and other miscellaneous accruals. The Trust accrues liabilities when costs are incurred and such costs can be reasonably estimated. Accrued expenses related to the Debtors’ bankruptcy are included in assumed liabilities on the accompanying balance sheet. Creditors’ Trust Funding Liability Pursuant to the Plan, in December 2016 and January 2017, the Trust contributed $2 million and $5 million respectively, to the Creditor’s Trust that was also established contemporaneously under the Plan. As of September 30, 2017, the Trust is obligated to fund an additional $5 million in January 2018. Premium Liability As of September 30, 2017 and December 31, 2016, the Trust holds $31.1 million and $25.8 million, respectively, in escrow for future payment of premium obligations. To the extent advanced premiums received from continuing fractional holders are not used for premium payments, they are refunded to the respective continuing fractional holder. Pre-Effective Maturity Liabilities On December 9, 2016, the Trust received funds related to maturities that occurred prior to the formation of the Trust. These funds are recognized as a liability on the accompanying balance sheet as pre-effective maturity liabilities owed to the fractional interest holders. Additionally, the Trust has recorded a receivable for maturities that occurred prior to December 9, 2016 where proceeds were not received as of that date. This receivable was $0 and $9.0 million as of September 30, 2017 and December 31, 2016 respectively and is included in pre-effective maturity liabilities on the accompanying balance sheet. Use of Estimates The preparation of these financial statements, in conformity with generally accepted accounting principles in the United States of America (“GAAP”), requires the Trust to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Actual results could differ from these estimates and such differences could be material. The estimates related to the valuation of the life insurance policies represent significant estimates made by the Trust. Risks and Uncertainties The Trust encounters economic, legal, and longevity risk. The two main components of economic risk potentially impacting the Trust are market risk and concentration of credit risk. The Trust’s market risks include interest rate risk and the risk of declines in valuation of the Trust’s life insurance policies, including declines caused by the selection of increased discount rates associated with the Trust’s fair value model. It is reasonably possible that future changes to estimates involved in valuing life insurance policies could change and result in material effects to the future financial statements. Concentration of credit risk is the risk that an insurance carrier who has issued life insurance policies held by the Trust, does not remit the amount due under those policies due to the deteriorating financial condition of the carrier or otherwise. Another credit risk potentially impacting the Trust is the risk continuing fractional holders may default on their future premium obligations, increasing the Trust’s premium liability. There exists a legal risk courts would allow insurance carriers to retain premiums paid by the Trust in respect of insurance policies that are successfully rescinded or contested. In addition, our title or right to benefit from an insurance policy may be challenged by the insurer or the insured’s family. Longevity risk refers to the reasonable possibility that actual mortalities of insureds in the Trust’s portfolio extend over longer periods than are anticipated, resulting in the Trust paying more for premiums. The Trust maintains the majority of its cash in several accounts with a commercial bank. Balances on deposit are insured by the Federal Deposit Insurance Corporation (“FDIC”). However, from time to time the Trust's balances may exceed the FDIC insurable amount at its banks. Description of Securities Units represent beneficial interests in the Trust, and all holders of Units are entitled to receive cash distributions from the Trust in accordance with their respective Pro Rata shares. A Trust beneficiary’s respective “Pro Rata Share” means the ratio, expressed as a percentage, of (i) the number of Units which such Trust beneficiary is the registered owner, to (ii) the total number of Units outstanding as of the measurement date, subject to modification for purposes of distributing any recovered assets. Initial units of Position Holder Trust Interest were issued on the basis of one (1) Unit for each $1 of death benefit payable (rounded to the nearest dollar) associated with the ownership of Fractional Positions. Subsequent issuances of Units will be issued to continuing fractional interest holders if they default on their premium payment obligations. Such Units will be issued in exchange for the defaulting position, in accordance with the basis and discounts delineated in the Plan, as recently modified by the Bankruptcy Court. Each Unit holder has the same rights with respect to each Unit as every other Unit holder. Unit holders do not have any voting rights under the Position Holder Trust Agreement with respect to the appointment of any successor to the Trustee, filling any vacancy on the Governing Trust Board or any action to be taken by the Position Holder Trust, including without limitation whether the duration of the Trust should be extended after the end of the initial 10-year term. Unit holders have no liability for the debts and other obligations of the Position Holder Trust and bear no expenses in connection with the organization and administration of the Trust. The Trust is a pass-through tax entity and its Unit holders may be allocated taxable income without a matching cash distribution, leading to an unfunded tax obligation. The Trust has the right, but not the obligation, to offset against any distributions allocated to any Unit holder in an amount equal to all unpaid amounts owed by the holder, including all unpaid amounts owed for catch-up payments, pre-petition default amounts and post-effective date payment defaults. Under the Plan, the Trustee will distribute at least annually to the Unit holders all of the distributable cash (as defined in the Position Holder Trust Agreement) generated during each calendar year, subject to any reserve established by the Trustee reasonably necessary to maintain the value of the Registrant’s assets or to meet claims and contingent liabilities. All distributions by the Trust will be made in accordance with such holder’s Pro Rata share of the outstanding Units. Continuing Fractional Interests The continuing fractional interest of a fractional interest holder who made a continuing holder election will represent 95% of the beneficial ownership associated with the Fractional Interest with respect to which the Election was made, with the other 5% comprising the Continuing Position Holder Contribution made to the Position Holder Trust on the Effective Date. The continuing fractional interest holder ("CFH") is obligated to pay 95% of the premium payments and policy expenses allocable to the fractional interest. Upon maturity of a Policy, the CFH with positions in the Policy will be entitled to receive the Policy proceeds allocable to each such continuing fractional interest held. The Policy proceeds paid to a CFH will be reduced by (1) the servicing fee payable with respect to each such continuing fractional interest, and (2) any premium amount paid by the Trust prior to the date of death with respect to the continuing fractional interest that is not refunded as a result of the maturity. Upon the occurrence of a payment default with respect to a continuing fractional interest, the CFH will be deemed to have contributed the position to the Trust at a discount of 20%, effective as of the payment default date. Recently Issued Accounting Pronouncements In November 2016, the FASB issued guidance under the Account Standards Update (“ASU”) 2016-18, Statement of Cash Flows: Restricted Cash, which provides guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flows. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. The Trust elected to adopt this provision early, and this adoption did not have a material impact on the Trust’s financial statements. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers,” which converges the FASB and the International Accounting Standards Board (“IASB”) standard on revenue recognition. Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. In April 2015, the FASB voted to defer the effective date of the new revenue recognition standard by one year. As a result, the provisions of this ASU are now effective for interim and annual periods beginning after December 15, 2017. The Trust does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows.

XML 16 R7.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2017
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 2 - Commitments and Contingencies Litigation In accordance with applicable accounting guidance, the Trust establishes an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. In such cases, there may be an exposure to loss in excess of any amounts accrued. When a loss contingency is not both probable and estimable, the Trust does not establish an accrued liability. As a litigation or regulatory matter develops, the Trust, in conjunction with any outside counsel handling the matter, evaluates on an ongoing basis whether such matter presents a loss contingency that is probable and estimable. If, at the time of evaluation, the loss contingency related to a litigation or regulatory matter is not both probable and estimable, the matter will continue to be monitored for further developments that would make such loss contingency both probable and estimable. When a loss contingency related to a litigation or regulatory matter is deemed to be both probable and estimable, the Trust will establish an accrued liability with respect to such loss contingency and record a corresponding amount of litigation-related expense. The Trust will then continue to monitor the matter for further developments that could affect the amount of any such accrued liability. Indemnification of Certain Persons Under certain circumstances, the Trust may be required to indemnify certain persons performing services on behalf of the Trust for liability they may incur arising out of the indemnified persons' activities conducted on behalf of the Trust. There is no limitation on the maximum potential payments under these indemnification obligations and, due to the number and variety of events and circumstances under which these indemnification obligations could arise, the Trust is not able to estimate such maximum potential payments. The Trust has not made any payments under such indemnification obligations and no amount has been accrued in the accompanying financial statements for these indemnification obligations of the Trust.

XML 17 R8.htm IDEA: XBRL DOCUMENT

Restricted Cash and Cash Equivalents	9 Months Ended
Restricted Cash and Cash Equivalents	Sep. 30, 2017
Restricted Cash and Cash Equivalents [Abstract]
Restricted Cash and Cash Equivalents	Note 3 - Restricted Cash and Cash Equivalents The Plan imposes restrictions on the Trust to maintain certain funds in segregated accounts. As of September 30, 2017 and December 31, 2016, the Trust has approximately $7.7 million and $26.2 million, respectively, in the pre-effective maturity escrow account which are distributable to the fractional interest holders in those policies that matured prior to the Plan becoming effective. The Plan further requires the Trust to maintain certain reserves in segregated accounts; as of September 30, 2017 and December 31, 2016, those reserves were approximately $44.4 million and $27.5 million, respectively. The Trust also maintains escrow accounts on behalf of the continuing fractional interest holders from which to fulfill their premium obligations; as of September 30, 2017 and December 31, 2016, the Trust held approximately $29.9 million and $25.8 million, respectively, on their behalf. See Note 1, "Premium Liability."

XML 18 R9.htm IDEA: XBRL DOCUMENT

Life Insurance Policies

9 Months Ended

Sep. 30, 2017

Life Insurance Policies [Abstract]

Life Insurance Policies

Note 4 - Life Insurance Policies

As of September 30, 2017:

Remaining Life Expectancy (Years)	Number of Life Insurance Policies		Face Value		Fair Value
0-1		25	$	56,207,688	$	43,884,176
1-2		44		69,880,054		42,137,638
2-3		64		81,805,300		35,859,153
3-4		57		87,802,823		28,775,972
4-5		108		181,159,206		42,876,670
Thereafter		2,879		807,373,873		92,622,111

Total		3,177	$	1,284,228,944	$	286,155,720

As of December 31, 2016:

Remaining Life Expectancy (Years)	Number of Life Insurance Policies		Face Value		Fair Value
0-1		19	$	26,906,072	$	22,344,600
1-2		29		59,109,822		38,672,708
2-3		60		53,027,573		26,251,734
3-4		59		95,930,412		35,577,890
4-5		86		112,725,236		29,193,315
Thereafter		2,999		942,298,899		111,538,793

Total		3,252	$	1,289,998,014	$	263,579,040

Estimated premiums to be paid by the Trust for its portfolio during each of the five succeeding fiscal years and thereafter as of September 30, 2017, are as follows:

2017	$	9,852,086
2018		43,706,522
2019		50,208,934
2020		51,169,045
2021		46,980,546
Thereafter		207,370,714

Total	$	409,287,847

The Trust anticipates funding the estimated premium payments from maturities of life insurance policies. It also maintains premium reserves and access to lines of credit.

- Definition

The entire disclosure for life settlement contracts including the accounting policy for life settlement contracts and the classification of cash receipts and cash disbursements in the statement of cash flows and, as applicable, for (1) life settlement contracts accounted for under the investment method based on the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, and (c) the face value (death benefits) of the life insurance policies underlying the contracts, (d) the life insurance premiums anticipated to be paid for each of the five succeeding fiscal years to keep the life settlement contracts in force as of the date of the most recent statement of financial position presented, (e) the nature of the information that causes the Entity to change its expectations on the timing of the realization of proceeds from the investments in life settlement contracts and the related effect on the timing of the realization of proceeds from the life settlement contracts and for (2) life settlement contracts accounted for under the fair value method, disclosure would include, based on remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, (c) the face value (death benefits) of the life insurance policies underlying the contracts, (d) the reasons for changes in the Entity's expectation of the timing of the realization of the investments in life settlement contracts, and (e) (i) the gains or losses recognized during the period on investments sold during the period and (ii) the unrealized gains or losses recognized during the period on investments that are still held at the date of the statement of financial position.

+ References + Details

XML 19 R10.htm IDEA: XBRL DOCUMENT

Notes Payable

9 Months Ended

Sep. 30, 2017

Notes Payable [Abstract]

Notes Payable

Note 5 - Notes Payable

Future scheduled principal payments on the above notes payable and required sinking fund contributions are as follows as of September 30, 2017:

	Sinking Fund		Notes Payable
2017	$	2,432,886	$	—
2018		2,432,886		55,000,000
2019		2,432,886		916,667
2020		2,432,886		916,667
2021		2,432,886		916,666
Thereafter		24,328,868		36,493,298
	$	36,493,298	$	94,243,298

XML 20 R11.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

9 Months Ended

Sep. 30, 2017

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 6 - Fair Value Measurements

Fair value measurements are classified based on the following fair value hierarchy:

The balances of the Trust's assets measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016, are as follows:

As of September 30, 2017:

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Investment in life insurance policies	$	—	$	—	$	286,155,720	$	286,155,720
	$	—	$	—	$	286,155,720	$	286,155,720

As of December 31, 2016:

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Investment in life insurance policies	$	—	$	—	$	263,579,040	$	263,579,040
	$	—	$	—	$	263,579,040	$	263,579,040

Quantitative Information about Level 3 Fair Value Measurements

Fair Value at

9/30/2017

Face value at

9/30/2017

Valuation

Technique(s)

Unobservable

Inputs

Range

(Weighted Average)

Life insurance policies

286,155,720

1,284,228,944

Discounted cash flow

Discount rate

25.2%-31.7

Life expectancy evaluation

3.6 years

		Fair Value at 12/31/16				Face value at 12/31/16			Valuation Technique(s)		Unobservable Inputs		Range (Weighted Average)
Life insurance policies		$	263,579,040			$	1,289,998,014		Discounted cash flow		Discount rate			24.7%-31.7	%

Fair Value at 12/31/16	Face value at 12/31/16	Valuation Technique(s)	Unobservable Inputs	Range (Weighted Average)

			Life expectancy evaluation	4.0 years

Following is a description of the methodologies used to estimate the assets’ fair value measured on a recurring basis and within the above fair value hierarchy.

Life expectancy sensitivity analysis

As of September 30, 2017 Life Expectancy Months Adjustment	Average life expectancy	Value		Change in Value
- 5%		$	301,220,686	$	15,064,966
No change	3.6 years	$	286,155,720	$	—
+ 5%		$	271,624,213	$	(14,531,507	)

As of December 31, 2016 Life Expectancy Months Adjustment	Average life expectancy	Value		Change in Value
- 5%		$	277,276,497	$	13,697,457
No change	4.0 years	$	263,579,040	$	—
+ 5%		$	249,069,410	$	(14,509,630	)

Discount rate

As of September 30, 2017 Rate Adjustment	Value		Change in Value
+2%	$	273,359,032	$	(12,796,688	)
No change	$	286,155,720	$	—
-2%	$	300,310,106	$	14,154,386

As of December 31, 2016 Rate Adjustment	Value		Change in Value
+2%	$	250,218,915	$	(13,360,125	)
No change	$	263,579,040	$	—
-2%	$	278,442,322	$	14,863,282

Credit Exposure to Insurance Companies

Carrier	Percentage of Face Value			Percentage of Fair Value			Carrier Rating
The Lincoln National Life Insurance		11.3	%		14.1	%		A	+
John Hancock Life Insurance (USA)		7.5	%		11.4	%		A	+
Transamerica Financial Life Insurance		9.1	%		11.1	%		A	+

Changes in Fair Value

The following table provides a roll-forward in the changes in fair value for the three and nine months ended September 30, 2017, for the Trust’s life insurance policies:

	Three months ended (unaudited)			Nine months ended (unaudited)
Beginning balance	$	273,147,684		$	263,579,040
Change in fair value		26,170,479			48,847,913
Matured policies, net of fees		(19,344,711	)		(50,870,826	)
Premiums paid		6,182,269			24,599,593

Ending balance	$	286,155,720		$	286,155,720

Changes in fair value included in earnings for the period relating to assets held at September 30, 2017	$	9,480,259		$	5,973,378

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 21 R12.htm IDEA: XBRL DOCUMENT

Operations and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Operations and Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Trust’s primary purpose is the liquidation of the Trust’s assets and the distribution of proceeds to its beneficial interest holders. The Trust expects that fulfilling its purpose requires a significant amount of time, and that the Trust will have significant ongoing operations during that period due to the nature of its assets and its plan to maximize the proceeds to its beneficiaries by maintaining the majority of its life insurance policies until maturity. As a result, the Trust has concluded that its liquidation is not imminent, in accordance with the definitions under accounting principles generally accepted in the United States of America, and has not applied the liquidation basis of accounting in presenting its financial statements. The Trust will continue to evaluate its operations to determine when its liquidation becomes imminent and the liquidation basis of accounting is required.
Investments in Life Insurance Policies	Investments in Life Insurance Policies The Trust accounts for its interests in life insurance policies at fair value in accordance with ASC 325-30, Investments in Insurance Contracts. The Trust initially recognized the life insurance policies transferred at its inception at their fair market value on December 9, 2016 and the Trust will estimate the fair value of its life insurance policies and recognize changes therein at each subsequent reporting period.
Fair Value of Life Insurance Policies	Fair Value of Life Insurance Policies The Trust follows ASC 820, Fair Value Measurements and Disclosures, in estimating the fair value of its life insurance policies, which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Trust’s investments in life insurance policies are considered to be Level 3 as there is currently no active market where the Trust is able to observe quoted prices for identical assets and the Trust’s valuation model incorporates significant inputs that are not observable. The Trust’s valuation of life insurance policies is a critical estimate within the financial statements. The Trust currently uses a probabilistic method of valuing life insurance policies, which the Trust believes to be the preferred valuation method in its industry. The Trust calculates the assets’ fair value using a present value technique to estimate the fair value of the projected future cash flows. The most significant assumptions in estimating the fair value are the Trust’s estimate of the insureds’ life expectancy and the discount rate. See Note 6, “Fair Value Measurements.”
Income Recognition	Income Recognition The Trust’s investments in life insurance policies are its primary source of income. Gain or loss is recognized from ongoing changes in the portfolio’s estimated fair value, including any gains or losses at maturity. Gains or losses from maturities are recognized at receipt of a death notice or verified obituary for an insured party, and determined based on the difference between the death benefit and the estimated fair value of the policy at maturity.
Premiums Receivable	Premiums Receivable The Trust assumed the Debtors’ receivables related to life insurance policy premiums and service fees that were paid by the Debtors on behalf of fractional interest holders prior to the Trust’s effective date. After December 9, 2016, the policy premiums allocable to continuing fractional interest holders are those persons' obligations and not the Trust. If a continuing fractional interest holder defaults on future premium obligations, such position is deemed contributed to the Trust in exchange for the number of Units provided by the Plan, as recently modified by the Bankruptcy Court The Trust maintains an allowance for doubtful accounts for estimated losses resulting from the inability to collect premiums and service fees receivable. Such estimates are based on the position holder’s payment history and other indications of potential uncollectability. After all attempts to collect a receivable have failed, receivables are written off against the allowance. At September 30, 2017 and December 31, 2016, the allowance for doubtful accounts was $5.0 million, all of which was for receivables assumed from the Debtors on the effective date. Outstanding receivable balances may be recoverable pursuant to the Trustee’s set-off rights under the Plan.
Maturities Receivable	Maturities Receivable Maturities receivable consist of the Trust’s portion of life insurance policy maturities that occurred but payment was not yet received.
Income Taxes	Income Taxes No provision for state or Federal income taxes has been made as the liability for such taxes is attributable to the Unit holders rather than the Trust. The Trust is a grantor trust with taxable income or loss passing through to the Unit holders. In certain instances, however, the Trust may be required under applicable state laws to remit directly to state tax authorities amounts otherwise due to Unit holders. Such payments on behalf of the Unit holders are deemed distributions to them. The Financial Accounting Standards Board (the “FASB”) has provided guidance for how uncertain tax positions should be recognized, measured, disclosed, and presented in the financial statements. This requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Trust’s tax returns to determine whether the tax positions are more-likely-than-not of being sustained when challenged or when examined by the applicable taxing authority. The Trust has no material uncertain income tax positions as of September 30, 2017 or December 31, 2016. The Trust also assumed income tax liabilities of the Debtors at its inception which total approximately $2.9 million as of September 30, 2017 and December 31, 2016 related to taxes, penalties, and interest from the Debtors’ 2008, 2009 and 2010 income tax returns. These obligations bear interest at 4% annually and are due in full by January 2020.
Accounts Payable and Accrued Expenses	Accounts Payable and Accrued Expenses Accounts payable and accrued expenses primarily include professional services, legal fees and expected litigation settlements, some of which are obligations assumed by the Trust that were incurred prior to the effective date of the Trust. The Trust also accrues liabilities for state taxes payable and other miscellaneous accruals. The Trust accrues liabilities when costs are incurred and such costs can be reasonably estimated. Accrued expenses related to the Debtors’ bankruptcy are included in assumed liabilities on the accompanying balance sheet.
Creditors' Trust Funding Liability	Creditors’ Trust Funding Liability Pursuant to the Plan, in December 2016 and January 2017, the Trust contributed $2 million and $5 million respectively, to the Creditor’s Trust that was also established contemporaneously under the Plan. As of September 30, 2017, the Trust is obligated to fund an additional $5 million in January 2018.
Premium Liability	Premium Liability As of September 30, 2017 and December 31, 2016, the Trust holds $31.1 million and $25.8 million, respectively, in escrow for future payment of premium obligations. To the extent advanced premiums received from continuing fractional holders are not used for premium payments, they are refunded to the respective continuing fractional holder.
Pre-Effective Maturity Liabilities	Pre-Effective Maturity Liabilities On December 9, 2016, the Trust received funds related to maturities that occurred prior to the formation of the Trust. These funds are recognized as a liability on the accompanying balance sheet as pre-effective maturity liabilities owed to the fractional interest holders. Additionally, the Trust has recorded a receivable for maturities that occurred prior to December 9, 2016 where proceeds were not received as of that date. This receivable was $0 and $9.0 million as of September 30, 2017 and December 31, 2016 respectively and is included in pre-effective maturity liabilities on the accompanying balance sheet.
Use of Estimates	Use of Estimates The preparation of these financial statements, in conformity with generally accepted accounting principles in the United States of America (“GAAP”), requires the Trust to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Actual results could differ from these estimates and such differences could be material. The estimates related to the valuation of the life insurance policies represent significant estimates made by the Trust.
Risks and Uncertainties	Risks and Uncertainties The Trust encounters economic, legal, and longevity risk. The two main components of economic risk potentially impacting the Trust are market risk and concentration of credit risk. The Trust’s market risks include interest rate risk and the risk of declines in valuation of the Trust’s life insurance policies, including declines caused by the selection of increased discount rates associated with the Trust’s fair value model. It is reasonably possible that future changes to estimates involved in valuing life insurance policies could change and result in material effects to the future financial statements. Concentration of credit risk is the risk that an insurance carrier who has issued life insurance policies held by the Trust, does not remit the amount due under those policies due to the deteriorating financial condition of the carrier or otherwise. Another credit risk potentially impacting the Trust is the risk continuing fractional holders may default on their future premium obligations, increasing the Trust’s premium liability. There exists a legal risk courts would allow insurance carriers to retain premiums paid by the Trust in respect of insurance policies that are successfully rescinded or contested. In addition, our title or right to benefit from an insurance policy may be challenged by the insurer or the insured’s family. Longevity risk refers to the reasonable possibility that actual mortalities of insureds in the Trust’s portfolio extend over longer periods than are anticipated, resulting in the Trust paying more for premiums. The Trust maintains the majority of its cash in several accounts with a commercial bank. Balances on deposit are insured by the Federal Deposit Insurance Corporation (“FDIC”). However, from time to time the Trust's balances may exceed the FDIC insurable amount at its banks.
Description of Securities	Description of Securities Units represent beneficial interests in the Trust, and all holders of Units are entitled to receive cash distributions from the Trust in accordance with their respective Pro Rata shares. A Trust beneficiary’s respective “Pro Rata Share” means the ratio, expressed as a percentage, of (i) the number of Units which such Trust beneficiary is the registered owner, to (ii) the total number of Units outstanding as of the measurement date, subject to modification for purposes of distributing any recovered assets. Initial units of Position Holder Trust Interest were issued on the basis of one (1) Unit for each $1 of death benefit payable (rounded to the nearest dollar) associated with the ownership of Fractional Positions. Subsequent issuances of Units will be issued to continuing fractional interest holders if they default on their premium payment obligations. Such Units will be issued in exchange for the defaulting position, in accordance with the basis and discounts delineated in the Plan, as recently modified by the Bankruptcy Court. Each Unit holder has the same rights with respect to each Unit as every other Unit holder. Unit holders do not have any voting rights under the Position Holder Trust Agreement with respect to the appointment of any successor to the Trustee, filling any vacancy on the Governing Trust Board or any action to be taken by the Position Holder Trust, including without limitation whether the duration of the Trust should be extended after the end of the initial 10-year term. Unit holders have no liability for the debts and other obligations of the Position Holder Trust and bear no expenses in connection with the organization and administration of the Trust. The Trust is a pass-through tax entity and its Unit holders may be allocated taxable income without a matching cash distribution, leading to an unfunded tax obligation. The Trust has the right, but not the obligation, to offset against any distributions allocated to any Unit holder in an amount equal to all unpaid amounts owed by the holder, including all unpaid amounts owed for catch-up payments, pre-petition default amounts and post-effective date payment defaults. Under the Plan, the Trustee will distribute at least annually to the Unit holders all of the distributable cash (as defined in the Position Holder Trust Agreement) generated during each calendar year, subject to any reserve established by the Trustee reasonably necessary to maintain the value of the Registrant’s assets or to meet claims and contingent liabilities. All distributions by the Trust will be made in accordance with such holder’s Pro Rata share of the outstanding Units.
Continuing Fractional Interests	Continuing Fractional Interests The continuing fractional interest of a fractional interest holder who made a continuing holder election will represent 95% of the beneficial ownership associated with the Fractional Interest with respect to which the Election was made, with the other 5% comprising the Continuing Position Holder Contribution made to the Position Holder Trust on the Effective Date. The continuing fractional interest holder ("CFH") is obligated to pay 95% of the premium payments and policy expenses allocable to the fractional interest. Upon maturity of a Policy, the CFH with positions in the Policy will be entitled to receive the Policy proceeds allocable to each such continuing fractional interest held. The Policy proceeds paid to a CFH will be reduced by (1) the servicing fee payable with respect to each such continuing fractional interest, and (2) any premium amount paid by the Trust prior to the date of death with respect to the continuing fractional interest that is not refunded as a result of the maturity. Upon the occurrence of a payment default with respect to a continuing fractional interest, the CFH will be deemed to have contributed the position to the Trust at a discount of 20%, effective as of the payment default date.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2016, the FASB issued guidance under the Account Standards Update (“ASU”) 2016-18, Statement of Cash Flows: Restricted Cash, which provides guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flows. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. The Trust elected to adopt this provision early, and this adoption did not have a material impact on the Trust’s financial statements. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers,” which converges the FASB and the International Accounting Standards Board (“IASB”) standard on revenue recognition. Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. In April 2015, the FASB voted to defer the effective date of the new revenue recognition standard by one year. As a result, the provisions of this ASU are now effective for interim and annual periods beginning after December 15, 2017. The Trust does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows.

XML 22 R13.htm IDEA: XBRL DOCUMENT

Life Insurance Policies (Tables)

9 Months Ended

Sep. 30, 2017

Life Insurance Policies [Abstract]

Trust's Life Insurance Policies Grouped by Remaining Life Expectancy

The following tables summarizes the Trust's life insurance policies grouped by remaining life expectancy as of September 30 ,2017 and December 31, 2016:

As of September 30, 2017:

Remaining Life Expectancy (Years)	Number of Life Insurance Policies		Face Value		Fair Value
0-1		25	$	56,207,688	$	43,884,176
1-2		44		69,880,054		42,137,638
2-3		64		81,805,300		35,859,153
3-4		57		87,802,823		28,775,972
4-5		108		181,159,206		42,876,670
Thereafter		2,879		807,373,873		92,622,111

Total		3,177	$	1,284,228,944	$	286,155,720

As of December 31, 2016:

Remaining Life Expectancy (Years)	Number of Life Insurance Policies		Face Value		Fair Value
0-1		19	$	26,906,072	$	22,344,600
1-2		29		59,109,822		38,672,708
2-3		60		53,027,573		26,251,734
3-4		59		95,930,412		35,577,890
4-5		86		112,725,236		29,193,315
Thereafter		2,999		942,298,899		111,538,793

Total		3,252	$	1,289,998,014	$	263,579,040

Estimated Premiums to be Paid by the Trust for its Portfolio

Estimated premiums to be paid by the Trust for its portfolio during each of the five succeeding fiscal years and thereafter as of September 30, 2017, are as follows:

2017	$	9,852,086
2018		43,706,522
2019		50,208,934
2020		51,169,045
2021		46,980,546
Thereafter		207,370,714

Total	$	409,287,847

XML 23 R14.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

9 Months Ended

Sep. 30, 2017

Notes Payable [Abstract]

Future Scheduled Principal Payments of Notes Payable and Sinking Fund Contributions

Future scheduled principal payments on the above notes payable and required sinking fund contributions are as follows as of September 30, 2017:

	Sinking Fund		Notes Payable
2017	$	2,432,886	$	—
2018		2,432,886		55,000,000
2019		2,432,886		916,667
2020		2,432,886		916,667
2021		2,432,886		916,666
Thereafter		24,328,868		36,493,298
	$	36,493,298	$	94,243,298

XML 24 R15.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value Measurements [Abstract]

Assets Measured at Fair Value on Recurring Basis

The balances of the Trust's assets measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016, are as follows:

As of September 30, 2017:

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Investment in life insurance policies	$	—	$	—	$	286,155,720	$	286,155,720
	$	—	$	—	$	286,155,720	$	286,155,720

As of December 31, 2016:

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Investment in life insurance policies	$	—	$	—	$	263,579,040	$	263,579,040
	$	—	$	—	$	263,579,040	$	263,579,040

Quantitative Information about Level 3 Fair Value Measurements

Fair Value at

9/30/2017

Face value at

9/30/2017

Valuation

Technique(s)

Unobservable

Inputs

Range

(Weighted Average)

Life insurance policies

286,155,720

1,284,228,944

Discounted cash flow

Discount rate

25.2%-31.7

Life expectancy evaluation

3.6 years

		Fair Value at 12/31/16				Face value at 12/31/16			Valuation Technique(s)		Unobservable Inputs		Range (Weighted Average)
Life insurance policies		$	263,579,040			$	1,289,998,014		Discounted cash flow		Discount rate			24.7%-31.7	%

Fair Value at 12/31/16	Face value at 12/31/16	Valuation Technique(s)	Unobservable Inputs	Range (Weighted Average)

			Life expectancy evaluation	4.0 years

Change in Estimated Fair Value

As of September 30, 2017 Life Expectancy Months Adjustment	Average life expectancy	Value		Change in Value
- 5%		$	301,220,686	$	15,064,966
No change	3.6 years	$	286,155,720	$	—
+ 5%		$	271,624,213	$	(14,531,507	)

As of December 31, 2016 Life Expectancy Months Adjustment	Average life expectancy	Value		Change in Value
- 5%		$	277,276,497	$	13,697,457
No change	4.0 years	$	263,579,040	$	—
+ 5%		$	249,069,410	$	(14,509,630	)

As of September 30, 2017 Rate Adjustment	Value		Change in Value
+2%	$	273,359,032	$	(12,796,688	)
No change	$	286,155,720	$	—
-2%	$	300,310,106	$	14,154,386

As of December 31, 2016 Rate Adjustment	Value		Change in Value
+2%	$	250,218,915	$	(13,360,125	)
No change	$	263,579,040	$	—
-2%	$	278,442,322	$	14,863,282

Changes in Fair Value for Trusts Life Insurance Policies

Changes in Fair Value

The following table provides a roll-forward in the changes in fair value for the three and nine months ended September 30, 2017, for the Trust’s life insurance policies:

	Three months ended (unaudited)			Nine months ended (unaudited)
Beginning balance	$	273,147,684		$	263,579,040
Change in fair value		26,170,479			48,847,913
Matured policies, net of fees		(19,344,711	)		(50,870,826	)
Premiums paid		6,182,269			24,599,593

Ending balance	$	286,155,720		$	286,155,720

Changes in fair value included in earnings for the period relating to assets held at September 30, 2017	$	9,480,259		$	5,973,378

XML 25 R16.htm IDEA: XBRL DOCUMENT

Operations and Significant Accounting Policies (Details)	1 Months Ended		9 Months Ended
	Jan. 31, 2017 USD ($)	Dec. 31, 2016 USD ($) Shareholder Policy shares	Sep. 30, 2017 USD ($) Shareholder Policy Component shares	Dec. 09, 2016 shares
Operations and Significant Accounting Policies [Abstract]
Number of units of beneficial interest issued to fractional interest holders (in shares) \| shares				1,012,355,948
Number of unit holders \| Shareholder		12,243	10,386
Number of units outstanding (in shares) \| shares		1,012,364,792	1,154,518,519
Number of life insurance policies \| Policy		3,252	3,177
Fair value of life insurance policies		$ 263,579,040	$ 286,155,720
Aggregate face value of life insurance policies		1,289,998,014	1,284,228,944
Premiums Receivable [Abstract]
Allowance for doubtful accounts		5,000,000	5,000,000
Income Taxes [Abstract]
Income tax liabilities of Debtors assumed		2,900,000	$ 2,900,000
Interest on income tax obligations			4.00%
Creditors' Trust Funding Liability [Abstract]
Contribution to creditor trust	$ 5,000,000	2,000,000
Outstanding funding obligation		10,000,000	$ 5,000,000
Premium Liability [Abstract]
Escrow for future payment of premium obligations		25,776,263	31,126,592
Pre-Effective Maturity Liabilities [Abstract]
Receivables for maturities included in pre-effective maturity liabilities		$ 9,000,000	$ 0
Risks and Uncertainties [Abstract]
Number of main components of economic risk \| Component			2
Description of Securities [Abstract]
Number of units issued for each dollar of death benefit payable (in shares) \| shares			1
Value of death benefit payable for each unit in Trust issued			$ 1
Initial term of trust agreement			10 years
Continuing Fractional Interests [Abstract]
Percentage of beneficial ownership by continuing fractional interest holder			95.00%
Percentage of beneficial ownership by position holder trust			5.00%
Percentage of premium payments and policy expenses allocable to fractional interest to be paid by continuing fractional interest			95.00%
Discount at which CFH will be deemed to have contributed the position to Trust upon payment default			20.00%

XML 26 R17.htm IDEA: XBRL DOCUMENT

Restricted Cash and Cash Equivalents (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Restricted Cash and Cash Equivalents [Abstract]
Pre-effective maturity escrow	$ 7,700,000	$ 26,200,000
Cash reserve	44,400,000	27,500,000
Escrow to fulfill premium obligations of continuing fractional interest holders	$ 29,900,000	$ 25.8

XML 27 R18.htm IDEA: XBRL DOCUMENT

Life Insurance Policies (Details)	9 Months Ended	12 Months Ended
Life Insurance Policies (Details)	Sep. 30, 2017 USD ($) Policy	Dec. 31, 2016 USD ($) Policy
Schedule of Life Settlement Contracts, Fair Value Method [Line Items]
Weighted average life expectancy	3 years 7 months 6 days	4 years
Number of life insurance policies [Abstract]
0-1 \| Policy	25	19
1-2 \| Policy	44	29
2-3 \| Policy	64	60
3-4 \| Policy	57	59
4-5 \| Policy	108	86
Thereafter \| Policy	2,879	2,999
Total \| Policy	3,177	3,252
Face value [Abstract]
0-1	$ 56,207,688	$ 26,906,072
1-2	69,880,054	59,109,822
2-3	81,805,300	53,027,573
3-4	87,802,823	95,930,412
4-5	181,159,206	112,725,236
Thereafter	807,373,873	942,298,899
Total	1,284,228,944	1,289,998,014
Fair value [Abstract]
0-1	43,884,176	22,344,600
1-2	42,137,638	38,672,708
2-3	35,859,153	26,251,734
3-4	28,775,972	35,577,890
4-5	42,876,670	29,193,315
Thereafter	92,622,111	111,538,793
Total	286,155,720	$ 263,579,040
Estimated premiums to be paid [Abstract]
2017	9,852,086
2018	43,706,522
2019	50,208,934
2020	51,169,045
2021	46,980,546
Thereafter	207,370,714
Total	$ 409,287,847
Life Settlement Policies [Member]
Number of life insurance policies [Abstract]
Total \| Policy	620	654
Face value [Abstract]
Total	$ 1,100,000,000	$ 1,100,000,000
Fair value [Abstract]
Total	$ 283,700,000	$ 261,600,000
Viaticals [Member]
Number of life insurance policies [Abstract]
Total \| Policy	2,577	2,598
Face value [Abstract]
Total	$ 180,400,000	$ 191,200,000
Fair value [Abstract]
Total	$ 2,500,000	$ 2,000,000

XML 28 R19.htm IDEA: XBRL DOCUMENT

Notes Payable (Details)		9 Months Ended	12 Months Ended
Notes Payable (Details)	Mar. 28, 2017 USD ($)	Sep. 30, 2017 USD ($) Payment	Dec. 31, 2016 USD ($)	Dec. 09, 2016 USD ($)
Revolving Line of Credit [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate				11.00%
Line of credit, maximum borrowing capacity				$ 25,000,000
Line of credit, maturity date		Dec. 09, 2018
Line of credit, outstanding amount		$ 0	$ 0
Sinking Fund [Member]
Debt Instrument [Line Items]
Debt instrument face amount		$ 36,500,000
Debt instrument, interest rate		3.00%
Debt instrument, maturity date		Dec. 09, 2031
Long term debt, outstanding amount		$ 36,493,298	36,500,000
Notes Payable [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Debt instrument face amount				$ 55,000,000
Debt instrument, interest rate				11.00%
Debt instrument, maturity date		Dec. 09, 2018
Long term debt, outstanding amount		$ 55,000,000	55,000,000
Notes Payable [Member] \| Notes Payable for Chapter 11 Trustee's Fees [Member]
Debt Instrument [Line Items]
Long term debt, outstanding amount		2,600,000	2,600,000
Trustee fees	$ 5,500,000
Trustee fee due amount			$ 2,800,000
Long term debt, gross		$ 2,800,000
Number of annual payments \| Payment		3
Note payable discount amount	$ 200,000
Implied interest rate			3.00%

XML 29 R20.htm IDEA: XBRL DOCUMENT

Notes Payable, Future Scheduled Principal Payments of Notes Payable and Sinking Fund Contributions (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Sinking Fund [Member]
Future scheduled principal payments [Abstract]
2017	$ 2,432,886
2018	2,432,886
2019	2,432,886
2020	2,432,886
2021	2,432,886
Thereafter	24,328,868
Long-term debt	36,493,298	$ 36,500,000
Notes Payable [Member]
Future scheduled principal payments [Abstract]
2017	0
2018	55,000,000
2019	916,667
2020	916,667
2021	916,666
Thereafter	36,493,298
Long-term debt	$ 94,243,298

XML 30 R21.htm IDEA: XBRL DOCUMENT

Fair Value Measurements, Assets Measured at Fair Value on Recurring Basis (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Assets [Abstract]
Fair value of life insurance policies	$ 286,155,720	$ 263,579,040
Recurring [Member]
Assets [Abstract]
Fair value of life insurance policies	286,155,720	263,579,040
Recurring [Member] \| Level 1 [Member]
Assets [Abstract]
Fair value of life insurance policies	0	0
Recurring [Member] \| Level 2 [Member]
Assets [Abstract]
Fair value of life insurance policies	0	0
Recurring [Member] \| Level 3 [Member]
Assets [Abstract]
Fair value of life insurance policies	$ 286,155,720	$ 263,579,040

XML 31 R22.htm IDEA: XBRL DOCUMENT

Fair Value Measurements, Quantitative Information about Level 3 Fair Value Measurements (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value of life insurance policies	$ 286,155,720	$ 263,579,040
Face value	$ 1,284,228,944	$ 1,289,998,014
Servicing fee payable percentage	2.65%
Mortality multipliers rate for life settlement male	100.00%
Mortality multipliers rate for life settlement female	100.00%
Mortality multipliers rate for viaticals regardless of gender	350.00%
Maximum life expectancy estimates for insureds considered reliable	90 years
Average age of the insureds for life settlements	89 years
Level 3 [Member] \| Life Settlement Policies [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Unobservable inputs	Life expectancy evaluation	Life expectancy evaluation
Life expectancy evaluation	3 years 7 months 6 days	4 years
Discounted Cash Flow [Member] \| Level 3 [Member] \| Life Settlement Policies [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value of life insurance policies	$ 286,155,720	$ 263,579,040
Face value	$ 1,284,228,944	$ 1,289,998,014
Unobservable inputs	Discount rate	Discount rate
Discounted Cash Flow [Member] \| Level 3 [Member] \| Life Settlement Policies [Member] \| Minimum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Discount rate	25.20%	24.70%
Discounted Cash Flow [Member] \| Level 3 [Member] \| Life Settlement Policies [Member] \| Maximum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Discount rate	31.70%	31.70%

XML 32 R23.htm IDEA: XBRL DOCUMENT

Fair Value Measurements, Change in Estimated Fair Value (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Life expectancy sensitivity analysis [Abstract]
Average life expectancy	3 years 7 months 6 days	4 years
Impact of -5% in life expectancy, value	$ 301,220,686	$ 277,276,497
No change, value	286,155,720	263,579,040
Impact of +5% in life expectancy, value	271,624,213	249,069,410
Impact of -5% change in life expectancy, change in value	15,064,966	13,697,457
Impact of +5% change in life expectancy, change in value	(14,531,507)	(14,509,630)
Discount rate [Abstract]
Impact of +2% in discount rate, value	273,359,032	250,218,915
No change, value	286,155,720	263,579,040
Impact of -2% in discount rate, value	300,310,106	278,442,322
Impact of +2% change in discount rate, change in value	(12,796,688)	(13,360,125)
Impact of -2% change in discount rate, change in value	$ 14,154,386	$ 14,863,282

XML 33 R24.htm IDEA: XBRL DOCUMENT

Fair Value Measurements, Life Insurance Issuer Concentrations (Details) - Credit Concentration Risk [Member] - Carrier A+ Rating [Member]	9 Months Ended
	Sep. 30, 2017
Face Value of Life Insurance Policies [Member] \| The Lincoln National Life Insurance [Member]
Concentration Risk [Line Items]
Concentrations risk percentage	11.30%
Face Value of Life Insurance Policies [Member] \| John Hancock Life Insurance (USA) [Member]
Concentration Risk [Line Items]
Concentrations risk percentage	7.50%
Face Value of Life Insurance Policies [Member] \| Transamerica Financial Life Insurance [Member]
Concentration Risk [Line Items]
Concentrations risk percentage	9.10%
Fair Value of Life Insurance Policies [Member] \| The Lincoln National Life Insurance [Member]
Concentration Risk [Line Items]
Concentrations risk percentage	14.10%
Fair Value of Life Insurance Policies [Member] \| John Hancock Life Insurance (USA) [Member]
Concentration Risk [Line Items]
Concentrations risk percentage	11.40%
Fair Value of Life Insurance Policies [Member] \| Transamerica Financial Life Insurance [Member]
Concentration Risk [Line Items]
Concentrations risk percentage	11.10%

XML 34 R25.htm IDEA: XBRL DOCUMENT

Fair Value Measurements, Changes in Fair Value (Details) - Life Insurance Policies [Member] - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2017
Changes in Fair Value [Roll Forward]
Beginning balance	$ 273,147,684	$ 263,579,040
Change in fair value	26,170,479	48,847,913
Matured policies, net of fees	(19,344,711)	(50,870,826)
Premiums paid	6,182,269	24,599,593
Ending balance	286,155,720	286,155,720
Changes in fair value included in earnings for the period relating to assets held at September 30, 2017	$ 9,480,259	$ 5,973,378

EXCEL 35 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 37 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 39 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 60 181 1 false 23 0 false 7 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://lpi-pht.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - BALANCE SHEETS (UNAUDITED) Sheet http://lpi-pht.com/role/BalanceSheetsUnaudited BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 020000 - Statement - STATEMENT OF OPERATIONS (UNAUDITED) Sheet http://lpi-pht.com/role/StatementOfOperationsUnaudited STATEMENT OF OPERATIONS (UNAUDITED) Statements 3 false false R4.htm 030000 - Statement - STATEMENT OF CHANGES IN NET ASSETS (UNAUDITED) Sheet http://lpi-pht.com/role/StatementOfChangesInNetAssetsUnaudited STATEMENT OF CHANGES IN NET ASSETS (UNAUDITED) Statements 4 false false R5.htm 040000 - Statement - STATEMENT OF CASH FLOWS (UNAUDITED) Sheet http://lpi-pht.com/role/StatementOfCashFlowsUnaudited STATEMENT OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 060100 - Disclosure - Operations and Significant Accounting Policies Sheet http://lpi-pht.com/role/OperationsAndSignificantAccountingPolicies Operations and Significant Accounting Policies Notes 6 false false R7.htm 060200 - Disclosure - Commitments and Contingencies Sheet http://lpi-pht.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 7 false false R8.htm 060300 - Disclosure - Restricted Cash and Cash Equivalents Sheet http://lpi-pht.com/role/RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents Notes 8 false false R9.htm 060400 - Disclosure - Life Insurance Policies Sheet http://lpi-pht.com/role/LifeInsurancePolicies Life Insurance Policies Notes 9 false false R10.htm 060500 - Disclosure - Notes Payable Notes http://lpi-pht.com/role/NotesPayable Notes Payable Notes 10 false false R11.htm 060600 - Disclosure - Fair Value Measurements Sheet http://lpi-pht.com/role/FairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 070100 - Disclosure - Operations and Significant Accounting Policies (Policies) Sheet http://lpi-pht.com/role/OperationsAndSignificantAccountingPoliciesPolicies Operations and Significant Accounting Policies (Policies) Policies http://lpi-pht.com/role/OperationsAndSignificantAccountingPolicies 12 false false R13.htm 080400 - Disclosure - Life Insurance Policies (Tables) Sheet http://lpi-pht.com/role/LifeInsurancePoliciesTables Life Insurance Policies (Tables) Tables http://lpi-pht.com/role/LifeInsurancePolicies 13 false false R14.htm 080500 - Disclosure - Notes Payable (Tables) Notes http://lpi-pht.com/role/NotesPayableTables Notes Payable (Tables) Tables http://lpi-pht.com/role/NotesPayable 14 false false R15.htm 080600 - Disclosure - Fair Value Measurements (Tables) Sheet http://lpi-pht.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://lpi-pht.com/role/FairValueMeasurements 15 false false R16.htm 090100 - Disclosure - Operations and Significant Accounting Policies (Details) Sheet http://lpi-pht.com/role/OperationsAndSignificantAccountingPoliciesDetails Operations and Significant Accounting Policies (Details) Details http://lpi-pht.com/role/OperationsAndSignificantAccountingPoliciesPolicies 16 false false R17.htm 090300 - Disclosure - Restricted Cash and Cash Equivalents (Details) Sheet http://lpi-pht.com/role/RestrictedCashAndCashEquivalentsDetails Restricted Cash and Cash Equivalents (Details) Details http://lpi-pht.com/role/RestrictedCashAndCashEquivalents 17 false false R18.htm 090400 - Disclosure - Life Insurance Policies (Details) Sheet http://lpi-pht.com/role/LifeInsurancePoliciesDetails Life Insurance Policies (Details) Details http://lpi-pht.com/role/LifeInsurancePoliciesTables 18 false false R19.htm 090500 - Disclosure - Notes Payable (Details) Notes http://lpi-pht.com/role/NotesPayableDetails Notes Payable (Details) Details http://lpi-pht.com/role/NotesPayableTables 19 false false R20.htm 090502 - Disclosure - Notes Payable, Future Scheduled Principal Payments of Notes Payable and Sinking Fund Contributions (Details) Notes http://lpi-pht.com/role/NotesPayableFutureScheduledPrincipalPaymentsOfNotesPayableAndSinkingFundContributionsDetails Notes Payable, Future Scheduled Principal Payments of Notes Payable and Sinking Fund Contributions (Details) Details 20 false false R21.htm 090600 - Disclosure - Fair Value Measurements, Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://lpi-pht.com/role/FairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements, Assets Measured at Fair Value on Recurring Basis (Details) Details 21 false false R22.htm 090602 - Disclosure - Fair Value Measurements, Quantitative Information about Level 3 Fair Value Measurements (Details) Sheet http://lpi-pht.com/role/FairValueMeasurementsQuantitativeInformationAboutLevel3FairValueMeasurementsDetails Fair Value Measurements, Quantitative Information about Level 3 Fair Value Measurements (Details) Details 22 false false R23.htm 090604 - Disclosure - Fair Value Measurements, Change in Estimated Fair Value (Details) Sheet http://lpi-pht.com/role/FairValueMeasurementsChangeInEstimatedFairValueDetails Fair Value Measurements, Change in Estimated Fair Value (Details) Details 23 false false R24.htm 090606 - Disclosure - Fair Value Measurements, Life Insurance Issuer Concentrations (Details) Sheet http://lpi-pht.com/role/FairValueMeasurementsLifeInsuranceIssuerConcentrationsDetails Fair Value Measurements, Life Insurance Issuer Concentrations (Details) Details 24 false false R25.htm 090608 - Disclosure - Fair Value Measurements, Changes in Fair Value (Details) Sheet http://lpi-pht.com/role/FairValueMeasurementsChangesInFairValueDetails Fair Value Measurements, Changes in Fair Value (Details) Details 25 false false All Reports Book All Reports lpi-20170930.xml lpi-20170930.xsd lpi-20170930_cal.xml lpi-20170930_def.xml lpi-20170930_lab.xml lpi-20170930_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2017-01-31 true true ZIP 41 0001140361-17-043457-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-17-043457-xbrl.zip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